Journal of Clinical Lipidology
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

3.86

7.8%

Journal Impact IF Trend

Related Journals

Popular Journals

Journal of Clinical Lipidology

The 2019-2020 Journal Impact IF of Journal of Clinical Lipidology is 3.86, which is just updated in 2020.

Journal of Clinical Lipidology Impact Factor
Highest IF
5.812
Highest Journal Impact IF

The highest Journal Impact IF of Journal of Clinical Lipidology is 5.812.

Lowest IF
1.583
Lowest Journal Impact IF

The lowest Journal Impact IF of Journal of Clinical Lipidology is 1.583.

Total Growth Rate
143.8%
IF Total Growth Rate

The total growth rate of Journal of Clinical Lipidology IF is 143.8%.

Annual Growth Rate
16.0%
IF Annual Growth Rate

The annual growth rate of Journal of Clinical Lipidology IF is 16.0%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Cardiology and Cardiovascular Medicine Q1 57/324

Cardiology and Cardiovascular Medicine 82%

Internal Medicine Q1 21/128

Internal Medicine 83%

Nutrition and Dietetics Q1 25/120

Nutrition and Dietetics 79%

Endocrinology, Diabetes and Metabolism Q1 45/217

Endocrinology, Diabetes and Metabolism 79%

Journal Impact IF Ranking

· In the Cardiology and Cardiovascular Medicine research field, the Quartile of Journal of Clinical Lipidology is Q1. Journal of Clinical Lipidology has been ranked #57 over 324 related journals in the Cardiology and Cardiovascular Medicine research category. The ranking percentile of Journal of Clinical Lipidology is around 82% in the field of Cardiology and Cardiovascular Medicine.
· In the Internal Medicine research field, the Quartile of Journal of Clinical Lipidology is Q1. Journal of Clinical Lipidology has been ranked #21 over 128 related journals in the Internal Medicine research category. The ranking percentile of Journal of Clinical Lipidology is around 83% in the field of Internal Medicine.
· In the Nutrition and Dietetics research field, the Quartile of Journal of Clinical Lipidology is Q1. Journal of Clinical Lipidology has been ranked #25 over 120 related journals in the Nutrition and Dietetics research category. The ranking percentile of Journal of Clinical Lipidology is around 79% in the field of Nutrition and Dietetics.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Journal of Clinical Lipidology is Q1. Journal of Clinical Lipidology has been ranked #45 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Journal of Clinical Lipidology is around 79% in the field of Endocrinology, Diabetes and Metabolism.

Journal of Clinical Lipidology Impact Factor 2020-2021 Prediction

Journal of Clinical Lipidology Impact Factor Predition System

Journal of Clinical Lipidology Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
2527
Total Citations
27717

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 3.86
2018-2019 3.581
2017-2018 3.58
2016-2017 5.812
2015-2016 4.906
2014-2015 3.904
2013-2014 3.587
2012-2013 2.741
2011-2012 1.583
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Journal of Clinical Lipidology is 3.86
· The 2018-2019 Journal Impact IF of Journal of Clinical Lipidology is 3.581
· The 2017-2018 Journal Impact IF of Journal of Clinical Lipidology is 3.58
· The 2016-2017 Journal Impact IF of Journal of Clinical Lipidology is 5.812
· The 2015-2016 Journal Impact IF of Journal of Clinical Lipidology is 4.906
· The 2014-2015 Journal Impact IF of Journal of Clinical Lipidology is 3.904
· The 2013-2014 Journal Impact IF of Journal of Clinical Lipidology is 3.587
· The 2012-2013 Journal Impact IF of Journal of Clinical Lipidology is 2.741
· The 2011-2012 Journal Impact IF of Journal of Clinical Lipidology is 1.583

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1980 0 4
1982 0 8
1983 0 2
1984 0 10
1985 0 4
1986 0 2
1987 0 4
1989 0 2
1990 0 5
1991 0 7
1992 0 4
1993 0 2
1994 0 2
1995 0 6
1996 0 4
1997 0 3
1998 0 1
1999 0 3
2000 0 1
2001 0 1
2002 0 1
2003 0 3
2004 0 3
2005 0 4
2006 0 4
2007 88 14
2008 115 95
2009 95 201
2010 149 371
2011 153 670
2012 147 1116
2013 165 1630
2014 163 2214
2015 208 2861
2016 264 3103
2017 336 3299
2018 211 3138
2019 209 3819
2020 220 4668
2021 3 428
Publications Cites Dataset

· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 1980.
· The Journal of Clinical Lipidology has published 0 reports and received 8 citations in 1982.
· The Journal of Clinical Lipidology has published 0 reports and received 2 citations in 1983.
· The Journal of Clinical Lipidology has published 0 reports and received 10 citations in 1984.
· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 1985.
· The Journal of Clinical Lipidology has published 0 reports and received 2 citations in 1986.
· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 1987.
· The Journal of Clinical Lipidology has published 0 reports and received 2 citations in 1989.
· The Journal of Clinical Lipidology has published 0 reports and received 5 citations in 1990.
· The Journal of Clinical Lipidology has published 0 reports and received 7 citations in 1991.
· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 1992.
· The Journal of Clinical Lipidology has published 0 reports and received 2 citations in 1993.
· The Journal of Clinical Lipidology has published 0 reports and received 2 citations in 1994.
· The Journal of Clinical Lipidology has published 0 reports and received 6 citations in 1995.
· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 1996.
· The Journal of Clinical Lipidology has published 0 reports and received 3 citations in 1997.
· The Journal of Clinical Lipidology has published 0 reports and received 1 citations in 1998.
· The Journal of Clinical Lipidology has published 0 reports and received 3 citations in 1999.
· The Journal of Clinical Lipidology has published 0 reports and received 1 citations in 2000.
· The Journal of Clinical Lipidology has published 0 reports and received 1 citations in 2001.
· The Journal of Clinical Lipidology has published 0 reports and received 1 citations in 2002.
· The Journal of Clinical Lipidology has published 0 reports and received 3 citations in 2003.
· The Journal of Clinical Lipidology has published 0 reports and received 3 citations in 2004.
· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 2005.
· The Journal of Clinical Lipidology has published 0 reports and received 4 citations in 2006.
· The Journal of Clinical Lipidology has published 88 reports and received 14 citations in 2007.
· The Journal of Clinical Lipidology has published 115 reports and received 95 citations in 2008.
· The Journal of Clinical Lipidology has published 95 reports and received 201 citations in 2009.
· The Journal of Clinical Lipidology has published 149 reports and received 371 citations in 2010.
· The Journal of Clinical Lipidology has published 153 reports and received 670 citations in 2011.
· The Journal of Clinical Lipidology has published 147 reports and received 1116 citations in 2012.
· The Journal of Clinical Lipidology has published 165 reports and received 1630 citations in 2013.
· The Journal of Clinical Lipidology has published 163 reports and received 2214 citations in 2014.
· The Journal of Clinical Lipidology has published 208 reports and received 2861 citations in 2015.
· The Journal of Clinical Lipidology has published 264 reports and received 3103 citations in 2016.
· The Journal of Clinical Lipidology has published 336 reports and received 3299 citations in 2017.
· The Journal of Clinical Lipidology has published 211 reports and received 3138 citations in 2018.
· The Journal of Clinical Lipidology has published 209 reports and received 3819 citations in 2019.
· The Journal of Clinical Lipidology has published 220 reports and received 4668 citations in 2020.
· The Journal of Clinical Lipidology has published 3 reports and received 428 citations in 2021.
· The total publications of Journal of Clinical Lipidology is 2527.
· The total citations of Journal of Clinical Lipidology is 27717.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Journal of Clinical Lipidology | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Journal of Clinical Lipidology Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Journal of Clinical Lipidology during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Journal of Clinical Lipidology.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Journal of Clinical Lipidology
Journal Profile

About

Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate. None

Highly Cited Keywords

ISSN
1933-2874
ISSN

The ISSN of Journal of Clinical Lipidology is 1933-2874 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
-
ISSN (Online)

The ISSN (Online) of Journal of Clinical Lipidology is - . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Elsevier BV
Publisher

Journal of Clinical Lipidology is published by Elsevier BV .

Publication Frequency
Bimonthly
Publication Frequency

Journal of Clinical Lipidology publishes reports Bimonthly .

Coverage
1970, 2007-2020
Coverage

The Publication History of Journal of Clinical Lipidology covers 1970, 2007-2020 .

Open Access
NO
Open Access

Journal of Clinical Lipidology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Journal of Clinical Lipidology. Journal of Clinical Lipidology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Journal of Clinical Lipidology is English .

Country/Region
Netherlands
Country/Region

The publisher of Journal of Clinical Lipidology is Elsevier BV , which locates in Netherlands .

Selected Articles

Full Title Authors
Full Title Authors
From the editor: What is the bottom line for clinical lipidology research? John R. Guyton · John R. Guyton
Case report—Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia Julius Katzmann · Carsten Schürfeld · Winfried März · Ulrich Laufs · Ulrich Laufs
PCSK9 inhibitors in familial hypercholesterolemia: What is the evidence? Martine Paquette · Robert A. Hegele · Alexis Baass · Alexis Baass
Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: a case report and literature review Ryoichi Ishibashi · Minoru Takemoto · Minoru Takemoto · Yuya Tsurutani · Masayuki Kuroda · Makoto Ogawa · Hanae Wakabayashi · Noriko Uesugi · Michio Nagata · Naofumi Imai · Akiko Hattori · Kenichi Sakamoto · Takumi Kitamoto · Yoshiro Maezawa · Ichiei Narita · Sadayuki Hiroi · Ayaka Furuta · Takashi Miida · Koutaro Yokote · Koutaro Yokote
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span Lauren Williams · Katherine S. Rhodes · Wahida Karmally · Lori A. Welstead · Lori Alexander · Lindsey Sutton · Lindsey Sutton
Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service Donald G. Lamprecht · Donald G. Lamprecht · Paul B. Shaw · Paul B. Shaw · Paul B. Shaw · Jordan B. King · Keri N. Hogan · Keri N. Hogan · Kari L. Olson · Kari L. Olson · Kari L. Olson
A novel homozygous ABCA1 variant in an asymptomatic man with profound hypoalphalipoproteinemia Yaser Carcora · Robert D. Brook · Linda Farhat · Cristen J. Willer · Melvyn Rubenfire · Daniel Seung Kim · Daniel Seung Kim
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia Martine Paquette · Robert Dufour · Alexis Baass · Alexis Baass
Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy Merel L Hartgers · Joost Besseling · Erik S.G. Stroes · Janneke Wittekoek · Joost Rutten · Jacqueline de Graaf · Frank L.J. Visseren · Ben P.M. Imholz · Jeanine E. Roeters van Lennep · Roeland Huijgen · John J. P. Kastelein · G. Kees Hovingh · G. Kees Hovingh
Familial hypercholesterolemia with extensive coronary artery disease and tuberous and tendinous xanthomas: A case report and mutation analysis Deniz Agirbasli · Tommy Hyatt · Mehmet Agirbasli · Mehmet Agirbasli
R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease and erectile dysfunction José M. Mostaza · Carlos Lahoz · Miguel A. Salinero-Fort · Olaya de Dios · Elisa Castillo · Teresa González-Alegre · Francisca García-Iglesias · Eva Estirado · Fernando Laguna · Concesa Sabín · Silvia López · Victor Cornejo · Carmen de Burgos · Vanesa Sanchez · Carmen Garcés · Belen Fernandez Puntero · Luis Montesano · Pedro PatronConcepción Aguilera Linde · Pedro J. Fernandez-Garcia · Concepción Aguilera Linde · Álvaro R. Aguirre De Carcer Escolano · Patricio Alonso. Sacristán · M. Jesús Álvarez Otero · Paloma Arribas Pérez · Maria Luisa. Asensio Ruiz · Pablo Astorga Díaz · Begoña Berriatua Ena · Ana Isabel Bezos Varela · María José Calatrava Triguero · Carlos Casanova García · Ángeles Conde Llorente · Concepción Diaz Laso · Emilia Elviro García · Orlando Enríquez Dueñas · María Isabel Ferrer Zapata · Froilán Antuña · Maria Isabel García Lazaro · Maria Teresa Gómez Rodríguez · África Gómez Lucena · Francisco Herrero Hernández · Rosa Julián Viñals · Gerardo López Ruiz Ogarrio · Maria Del Carmen Lumbreras Manzano · Sonsoles Paloma Luquero López · Ana Martinez Cabrera Peláez · Montserrat Nieto Candenas · María Alejandra Rabanal Carrera · Ángel Castellanos Rodríguez · Ana López Castellanos · Milagros Velazquez García · Margarita Ruiz Pacheco · Margarita Ruiz Pacheco
Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men Katya B. Rubinow · Tomas Vaisar · Jing H. Chao · Jay W. Heinecke · Stephanie T. Page · Stephanie T. Page
Variations in time to benefit among clinical trials of cholesterol-lowering drugs Philip J. Barter · Philip J. Barter · David D. Waters · David D. Waters · David D. Waters
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study Leopoldo Pérez de Isla · Rodrigo Alonso · Ovidio Muñiz-Grijalvo · José Luis Díaz-Díaz · Daniel Zambón · José P. Miramontes · Francisco Fuentes · José Juan Gómez de Diego · Aurora González-Estrada · Nelva Mata · Adriana Saltijeral · Manuel Barreiro · Marta Tomás · Raimundo de Andrés · Rosa Argueso · María del Pilar Serrano Gotarredona · Silvia Navarro Herrero · Rosario J. Perea Palazón · Teresa M. de Caralt · Luisa Arrojo Suárez de Centi · Svetlana Zhilina · Simona Espejo Pérez · Teresa Padró · Pedro Mata · Pedro Mata
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study Michael Davidson · Michael Stevenson · Andrew Hsieh · Zahid Ahmad · Jeanine E. Roeters van Lennep · Caroline Crowson · Joseph L. Witztum · Joseph L. Witztum
Roundtable discussion: Dietary fats in prevention of atherosclerotic cardiovascular disease Tracy Severson · Penny M. Kris-Etherton · Jennifer G. Robinson · John R. Guyton · John R. Guyton
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins Baiba K. Gillard · Baiba K. Gillard · Corina Rosales · Corina Rosales · Bingqing Xu · Antonio M. Gotto · Antonio M. Gotto · Henry J. Pownall · Henry J. Pownall · Henry J. Pownall
Identification of proresolving and inflammatory lipid mediators in human psoriasis Alexander V. Sorokin · Paul C. Norris · Justin T. English · Amit K. Dey · Abhishek Chaturvedi · Yvonne Baumer · Joanna Silverman · Martin P. Playford · Charles N. Serhan · Nehal N. Mehta · Nehal N. Mehta
Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease D. Chieng · Jing Pang · Katrina L. Ellis · Graham S. Hillis · Gerald F. Watts · Gerald F. Watts · Carl Schultz · Carl Schultz · Carl Schultz
Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics Marie-Soleil Gauthier · Zuhier Awan · Zuhier Awan · Annie Bouchard · Josée Champagne · Sylvain Tessier · Denis Faubert · Katherine Chabot · Pierre Garneau · Rémi Rabasa-Lhoret · Nabil G. Seidah · Paul M. Ridker · Jacques Genest · Benoit Coulombe · Benoit Coulombe
Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab Paul M. Ridker · Lynda Rose · John J. P. Kastelein · Raul D. Santos · Caimiao Wei · James H. Revkin · Carla Yunis · Jean-Claude Tardif · Charles L. Shear · Charles L. Shear
Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease Shima Dowla · Stella Aslibekyan · Amy M. Goss · Kevin R. Fontaine · Ambika P. Ashraf · Ambika P. Ashraf
Severe xanthomatosis in heterozygous familial hypercholesterolemia Sumayah Aljenedil · Isabelle Ruel · Kevin Watters · Jacques Genest · Jacques Genest
Assessment of Lipid Profile in Patients Referred Via the Primary PCI Pathway. Are We Missing Patients with Familial Hypercholesterolaemia Samir Elgerray · Gregory Oleszkiewicz · Zuhaina Haque · Akhlaque Uddin · Akhlaque Uddin
Relationship Between Dyslipidemia and Short Stature in Adults; from the Korean NHANES Survey Mi-Jung Park · Mi-Jung Park
Association between high-density lipoprotein subfractions and low-grade inflammation, insulin resistance and metabolic syndrome components: The ELSA-Brasil Study Giuliano Generoso · Isabela M. Benseñor · Raul D. Santos · Itamar S. Santos · Alessandra C. Goulart · Steven R. Jones · Krishnaji R. Kulkarni · Michael J. Blaha · Peter P. Toth · Paulo A. Lotufo · Marcio Sommer Bittencourt · Marcio Sommer Bittencourt
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study Daniel Gaudet · Gisle Langslet · Samuel S. Gidding · Ilse K. Luirink · Andrea Ruzza · Christopher Kurtz · Chen Lu · Ransi Somaratne · Frederick J. Raal · Albert Wiegman · Albert Wiegman
Familial hypercholesterolemia and cardiovascular risk stratification S. Mirzaee · James D. Cameron · James D. Cameron
Treatment related and Health related Quality of Life in Lipoprotein Apheresis Patients V. De Gucht · K. Cromm · Anja Vogt · Ulrich Julius · Bernd Hohenstein · R.M. Spitthöver · W. Ramlow · V.J.J. Schettler · Stan Maes · Stan Maes
Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia Shizuya Yamashita · Hidenori Arai · Koutaro Yokote · Eiichi Araki · Hideki Suganami · Shun Ishibashi · Shun Ishibashi
Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China Xingguang Zhang · Jing Liu · Miao Wang · Yue Qi · Jiayi Sun · Jun Liu · Ying Wang · Yongchen Hao · Yan Li · Mengge Zhou · Dong Zhao · Dong Zhao
Statins in children: A monocentric experience Paola Sabrina Buonuomo · Gerarda Mastrogiorgio · Marina Macchiaiolo · Ippolita Rana · Michaela Veronika Gonfiantini · Denise Pires Marafon · Andrea Bartuli · Andrea Bartuli
Clinical and cost benefits of medical nutrition therapy by registered dietitian nutritionists for management of dyslipidemia: A systematic review and meta-analysis Geeta Sikand · Renee E. Cole · Deepa Handu · Desiree deWaal · Joanne Christaldi · Elvira Q. Johnson · Linda M. Arpino · Shirley M. Ekvall · Shirley M. Ekvall
Ethnic differences in plasma lipid levels in a large multiethnic cohort: The HELIUS study Katia Gazzola · Marieke B. Snijder · G. Kees Hovingh · Erik S.G. Stroes · Ron J. G. Peters · Bert-Jan H. van den Born · Bert-Jan H. van den Born
Some children with a familial hypercholesterolemia mutation may exhibit persistent low LDL levels Gisle Langslet · Martin P. Bogsrud · Cecilie Wium · Dan Johansen · Arne Svilaas · Kirsten B. Holven · Kirsten B. Holven
Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial Rocío Mateo-Gallego · Laura Lacalle · Sofía Pérez-Calahorra · Victoria Marco-Benedí · Valle Recasens · Noelia Padrón · Itziar Lamiquiz-Moneo · Lucía Baila-Rueda · Estíbaliz Jarauta · Pilar Calmarza · Ana Cenarro · Fernando Civeira · Fernando Civeira
Lp8 is potentially associated with partial lecithin:cholesterol acyltransferase deficiency in a patient with primary biliary cirrhosis Toshiyuki Watanabe · Toshirou Nema · Nobuyuki Hiruta · Takeyoshi Murano · Wolfgang J. Schneider · Hideaki Bujo · Hideaki Bujo
Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis P. Barton Duell · Gerald Salen · Florian Eichler · Andrea E. DeBarber · Sonja L. Connor · Lise Casaday · Suman Jayadev · Yasushi Kisanuki · Patamaporn Lekprasert · Mary J. Malloy · Ritesh A. Ramdhani · Paul E. Ziajka · Joseph F. Quinn · Kimmy G. Su · Andrew S. Geller · Margaret R. Diffenderfer · Ernst J. Schaefer · Ernst J. Schaefer
Personalized regimen for PCSK9 inhibitors: A therapeutic option that maintains efficacy and reduces costs Tiziana Sampietro · Federico Bigazzi · Francesco Sbrana · Maddalena Toma · Beatrice Dal Pino · Andrea Ripoli · Michele Coceani · Roberta Luciani · Mascia Pianelli · Mascia Pianelli
First case of sitosterolemia caused by double heterozygous mutations in ABCG5 and ABCG8 genes Hayato Tada · Akihiro Nomura · Masakazu Yamagishi · Masa-aki Kawashiri · Masa-aki Kawashiri
Combination therapy of omega-3 fatty acids and acipimox for children with hypertriglyceridemia and acute lymphoblastic leukemia C. Salvador · A. Entenmann · R. Salvador · A. Niederwanger · R. Crazzolara · G. Kropshofer · G. Kropshofer
The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: A systematic review and meta-analysis S. Mirzaee · P. Thein · Jason Nogic · Nitesh Nerlekar · Arthur Nasis · Adam J. Brown · Adam J. Brown
Taking a look under the hood—imaging the phenotypic heterogeneity of familial hypercholesterolemia Michael D. Shapiro · Sergio Fazio · Sergio Fazio
PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results? Massimo Raffaele Mannarino · Amirhossein Sahebkar · Amirhossein Sahebkar · Vanessa Bianconi · Maria-Corina Serban · Maciej Banach · Matteo Pirro · Matteo Pirro
PCSK9 monoclonal antibody on a knife-edge: an article of faith in FH? Natalie C. Ward · Natalie C. Ward · Gerald F. Watts · Gerald F. Watts · Gerald F. Watts
Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin Beth A. Taylor · Beth A. Taylor · Gregory A. Panza · Gregory A. Panza · Kevin D. Ballard · C Michael White · C Michael White · Paul D. Thompson · Paul D. Thompson · Paul D. Thompson
Old news and a new order John R. Guyton · John R. Guyton
The ODYSSEY Outcomes trial: Clinical implications and exploration of the limits of what can be achieved through lipid lowering Kevin C. Maki · Kevin C. Maki
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse Anum Saeed · Salim S. Virani · Peter H. Jones · Christie M. Ballantyne · Vijay Nambi · Vijay Nambi
Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration Cezary Wójcik · Sergio Fazio · Adam D. McIntyre · Robert A. Hegele · Robert A. Hegele
Pediatric Lipid Reference Values in the General Population: the Dutch Lifelines Cohort Study Jan W. Balder · Peter Lansberg · M.H. Hof · Albert Wiegman · Barbara A. Hutten · Jan Albert Kuivenhoven · Jan Albert Kuivenhoven
A failure of standardization or a failure of the process of standardization Allan D. Sniderman · Matthew J. McQueen · Matthew J. McQueen
Do Biomarkers Improve Short-term Risk Prediction of Global Cardiovascular Events in Older Adults? Insights from the Atherosclerosis Risk in Communities Study* Anum Saeed · Vijay Nambi · Wensheng Sun · Salim S. Virani · George E. Taffet · Anita Deswal · Elizabeth Selvin · Kunihiro Matsushita · Lynne E. Wagenknecht · Ron C. Hoogeveen · Josef Coresh · James A. de Lemos · Christie M. Ballantyne · Christie M. Ballantyne
Community Educational Program Decreases Total Cholesterol in 2 weeks Francisco E. Ramirez · Neil Nedley · Rubisel Ramírez de la Cruz · Sialy Montes · Omayra Mulero · Cesar Perez · Lilia Michelle Villegas · Lilia Michelle Villegas
Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS † Andres Gelrud · Andres DiGenio · Veronica J. Alexander · Karren Williams · Andrew Hsieh · Ioanna Gouni-Berthold · Eric Bruckert · Erik S.G. Stroes · Richard S. Geary · Steven G. Hughes · Sam Tsimikas · Joseph L. Witztum · Daniel Gaudet · Daniel Gaudet
Prevalence of Cardiovascular Risk Factors among Patients Presenting with Premature Myocardial Infarction in the Middle East Sagar Dugani · Zareen Farukhi · Karisamae Damilig · Edward Lance Callachan · Waheed Murad · Abubaker Elfatih · Salwa Yusef · Eiman Al Zaabi · Robert J. Glynn · M.V. Moorthy · Bassem Mora · Ahlam Alawadhi · Abdulkarim Saleh · Arif Al-Mulla · Alawi A. Alsheikh-Ali · Alawi A. Alsheikh-Ali
LTP Prodrug Technology Offers Opportunity of New Generation Lipid Lowering Agents Lin Zhi · Eric G. Vajda · Keith B. Marschke · Keith B. Marschke
Effect of Sebelipase Alfa Administered for 20 Weeks on Serum Lipoprotein Levels In Patients with Lysosomal Acid Lipase Deficiency Having Identical LIPA Mutations versus Multiple LIPA Mutations James J. Maciejko · Premchand Anne · D. Freeman · Hernando Lyons · Hernando Lyons
Impact of Clinical Pharmacy Managed Service on PCSK9 Inhibitior Use Khaled Dajani · Michael Danning · Michael Danning
Prevalence of Diabetes and Statin Treatment in Youth Elmor Pineda · Catherine J. McNeal · I-Chia Liao · Pj Godley · Pj Godley
Elevated Lipoprotein (a) Masquerading as Homozygous Familial Hypercholesterolemia Anish Vani · Vanessa Hurta · James Underberg · James Underberg
Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service Barak Zafrir · Barak Zafrir · Ayman Jubran · Ayman Jubran · Rawan Hijazi · Rawan Hijazi · Chen Shapira · Chen Shapira · Chen Shapira
Familial Chylomicronemia and Population Prevalence of Marked Hypertriglyceridemia Vadzim Chyzhyk · Ernst J. Schaefer · Margaret R. Diffenderfer · Robert A. Hegele · Alan S. Brown · Alan S. Brown
Underlying Causes and Management of Patients with Triglycerides > 2000 mg/dL † Zahid Ahmad · Maria Esparza · Maria Esparza
Low Vitamin D, but not Creatine Supplementation, Alters the Creatine Kinase Response to Eccentric Exercise in Healthy Adults on Atorvastatin Beth A. Taylor · Gregory A. Panza · Kevin D. Ballard · White Cm · Paul D. Thompson · Paul D. Thompson
Familial Hypercholesterolemia Screening Practices Across Mayo Subspecialties Regis I. Fernandes · Katie L. Kunze · Katie L. Kunze
ApoA1 Remnant Ratio in Very High Risk Patients with LDL-c 55 Years of Age John Nelson · Lihong He · Michael Dansinger · Michael Dansinger
Effect of Lipoprotein Apheresis via Liposorber System versus Plasmapheresis on LDL-cholesterol for Two Patients with Familial Hypercholesterolemia* Elisa Baddour · Melissa Snider · Jason Evanchan · Jason Evanchan
Low density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus Greer A. Burkholder · Paul Muntner · Hong Zhao · Michael J. Mugavero · E. Turner Overton · Meredith L. Kilgore · Daniel R. Drozd · Heidi M. Crane · Richard D. Moore · Wm. Christopher Mathews · Elvin Geng · Stephen Boswell · Michelle Floris-Moore · Robert S. Rosenson · Robert S. Rosenson
Injection Site Reactions to PCSK9i Monoclonal Antibody Therapies are caused by Polysorbates in the Products Craig Stark · Christine Hartman · Hanns-Christian Mahler · Satish K. Singh · Satish K. Singh
Examing the High Disease Burden and Impact on Quality of Life in Familial Chylomicronemia Syndrome Michael Davidson · Michael Stevenson · Andrew Hsieh · Zahid Ahmad · Jeanine Roeters van Lennep · Joseph L. Witztum · Joseph L. Witztum
Prevalence and Predictors of Residual Hypertriglyceridemia According to Statin Use in US Adults Wenjun Fan · Sephy Philip · Craig Granowitz · Peter P. Toth · Nathan D. Wong · Nathan D. Wong
Human Atherosclerotic Carotid Artery Plaques with Cholesterol Crystals Enhance Bacterial Growth: Risk for Plaque Destabilization* Manel Boumegouas · Joseph C. Gardiner · Abed Janoudi · Heather De Feijter-Rupp · Ara Pridjian · George S. Abela · George S. Abela
High Triglycerides and ASCVD Are Significant Predictors of Major CV Events and Increased Costs in Statin-Treated Patients: Real-World Analysis Peter P. Toth · Craig Granowitz · Michael Hull · Sephy Philip · Sephy Philip
Cardiovascular Disease Risk Factor Response to a Type 2 Diabetes Care Model Including Nutritional Ketosis at One Year Amy L. McKenzie · Nasir H. Bhanpuri · Sarah Hallberg · Paul T. Williams · Kevin D. Ballard · James P. McCarter · Stephen D. Phinney · Jeff S. Volek · Jeff S. Volek
Hypertriglyceride-Induced Pancreatitis Study (HIPS) Debra Friedrich · Paul E. Ziajka · Sandra Kreul · Sudha Ravilla · Sudha Ravilla
Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial Peter P. Toth · Steven R. Jones · April Slee · Jerome L. Fleg · Santica M. Marcovina · Megan Lacy · Ruth McBride · William E. Boden · William E. Boden
Undetectable high-density lipoprotein cholesterol in acute malaria Ana Rakovac Tisdall · Vivion Edward Francis Crowley · Martin A. Crook · Martin A. Crook
The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial Abdulhamied Alfaddagh · Tarec K. Elajami · Mohamad Saleh · Mohamad Elajami · Bruce R. Bistrian · Francine K. Welty · Francine K. Welty
Three Week NEWSTART Intervention Improve Laboratories of Patients Francisco E. Ramirez · Amy Krueger · Neil Nedley · Lilia Michelle Villegas · Lilia Michelle Villegas
Statin Use is Associated with Lower Trimethylamine-N-oxide (TMAO) Level in Adults at Risk of Atherosclerotic Cardiovascular Disease, Independent of Serum Cholesterol and Renal Function. * Michael Milks · Xin He · Travis Sharkey-Toppen · Suzanne Smart · Beth McCarthy · Arpad Somogyi · Martha A. Belury · Subha V. Raman · Subha V. Raman
From the editor: Weighing the advantages of lipid conference and journal John R. Guyton · John R. Guyton
A 10 Year Old Female with Low HDL Cholesterol Luke Hamilton · Don P. Wilson · Don P. Wilson
Efficacy of Lomitapide Across the Spectrum of Homozygous Familial Hypercholesterolemia Robert A. Hegele · Prediman K. Shah · Kenneth DiGioia · Agnieszka Jurecka · Dirk Blom · Dirk Blom
Supravalvular Aortic Stenosis in a Patient with Lysosomal Acid Lipase Deficiency Premchand Anne · James J. Maciejko · Mary MacLeod · Mary MacLeod
Characterization of Statin Therapy in a Managed Care Population with Diabetes Sarah L. Anderson · Joel C. Marrs · Joel C. Marrs
Evaluating the Impact of Peer Support and Connection on the Quality of Life of Patients with Familial Chylomicronemia Syndrome Valerie Salvatore · Alan Gilstrap · Karren Williams · Andrew Hsieh · A. R. Gwosdow · Michael Stevenson · David Davidson · David Davidson
Self-reported Lifestyle Behaviors in Younger versus Older Patients with Newly Diagnosed Cardiovascular Disease* Michael Garshick · Georgeta Vaidean · James Underberg · Eugenia Gianos · Eugenia Gianos
Pompe Disease Masquerading as Statin Induced Myopathy Raneem Milyani · Raneem Milyani
Atherosclerotic Risk Based on Calcium Score in Primary Biliary Cholangitis Jordan Kunkes · William Lane Duvall · Sidney Olefson · Heather Swales · Swales Colin · Paul D. Thompson · Paul D. Thompson
When a Target LDL-C Goal of Less Than 70mg/dl is Not Enough Isha Verma · Antonio B. Fernandez · Stephanie Saucier · Stephanie Saucier
Plasma EPA(Eicosapentaenoic Acid)/AA (Arachidonic Acid) Ratio in Patients With Stage 5 Chronic Kidney Disease: A Novel, Treatable Target? John Nelson · Lihong He · Rosalynn Gill · Michael L. Dansinger · Michael L. Dansinger
Tailoring Statin Therapy to Reduce The Risk of New-Onset Diabetes: Success of Online CME Jelena Spyropoulos · Joy Marko · Colleen Healy · Colleen Healy
Insulin Resistance Across the Triglyceride Continuum; Even Further than Expected? John Nelson · Brett Milburn · Michael Dansinger · Michael Dansinger
LDL-C Therapeutic Target Attainment in Patients with Homozygous Familial Hypercholesterolemia treated with Lomitapide James Underberg · Mariko Harada-Shiba · Robert A. Hegele · Peter A. McCullough · Kenneth DiGioia · Agnieszka Jurecka · Claudia Stefanutti · Dirk Blom · Dirk Blom
Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study Jeffrey L. Anderson · Jeffrey L. Anderson · Kirk U. Knowlton · Kirk U. Knowlton · Heidi T May · Tami L. Bair · Shannon O. Armstrong · Donald L. Lappé · Joseph B. Muhlestein · Joseph B. Muhlestein · Joseph B. Muhlestein
Familial Hypercholesteremia: When Statins, Ezetimibe & PCSK9 Inhibitors Are Not Enough Isha Verma · Paul D. Thompson · Antonio B. Fernandez · Antonio B. Fernandez
Treatment Effects of Different Lipid Lowering Regimens on Remnant Cholesterol Daniel Isquith · Xue-Qiao Zhao · J. Feller · Susan McKeeth · Elizabeth Hulphers · Hua Bai · Pey Shadzi · Jayne Williamson · Jayne Williamson
Effect of PCSK9 Inhibitors on Plasma Ceramide Levels Qian Ye · Jeffrey W. Meeusen · Anna Svatikova · Stephen L. Kopecky · Stephen L. Kopecky
Management of Dyslipidemia: Virtual Simulation Improves Clinical Decision-Making Jelena Spyropoulos · Piyali Chatterjee · Michael LaCouture · Doug Blevins · Colleen Healy · Colleen Healy
Identifying Risk Factors of Atherosclerotic Cardiovascular Disease in the South Asian Population Casey Elkins · Jennie Gunn · Loretta Jones · Tracey Taylor · Kathryn Bydalek · Sharon Fruh · Sharon Fruh
Finding Familial Hypercholesterolemia in African American Women at a Community Cardiovascular Screening Event Gina P. Lundberg · Pratik Sandesara · Pratik Sandesara
The additive effect of adherence to multiple healthy lifestyles on subclinical atherosclerosis: Insights from the AWHS Irina Uzhova · Rocio Mateo-Gallego · Belén Moreno-Franco · Belén Moreno-Franco · Esther Molina-Montes · Montserrat León-Latre · José A. Casasnovas Lenguas · José A. Casasnovas Lenguas · Fernando Civeira · Fernando Civeira · José L. Peñalvo · José L. Peñalvo
High-density lipoprotein cholesterol and causes of death in chronic kidney disease Sankar D. Navaneethan · Jesse D. Schold · Carl P. Walther · Susana Arrigain · Stacey E. Jolly · Salim S. Virani · Wolfgang C. Winkelmayer · Joseph V. Nally · Joseph V. Nally
A Case of Cerebrotendinous Xanthomatosis Andrew S. Geller · Patamaporn Lekprasert · Margaret R. Diffenderfer · Ernst J. Schaefer · Ernst J. Schaefer
Should children with chronic diarrhea be referred to a lipid clinic Don P. Wilson · Nivedita Patni · Nivedita Patni
Highly efficacious, long-term, triglyceride lowering with rituximab therapy in a patient with autoimmune hypertriglyceridemia Sophie Béliard · Mathilde Di Filippo · G. Kaplanski · René Valéro · René Valéro
Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting Jesús M. Martín-Campos · Núria Plana · Rosaura Figueras · Daiana Ibarretxe · Assumpta Caixàs · Eduardo Esteve · Antonio Pérez · Marta Bueno · Marta Mauri · Rosa Roig · Susana Martínez · Xavier Pintó · Luis Masana · Josep Julve · Francisco Blanco-Vaca · Francisco Blanco-Vaca
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia Miklós Péterfy · Miklós Péterfy · Miklós Péterfy · Candy Bedoya · C. Giacobbe · Carmen Pagano · Marco Gentile · Paolo Rubba · Giuliana Fortunato · Maria Donata Di Taranto · Maria Donata Di Taranto
Use of cardiovascular risk scores in acute coronary syndrome patients with familial hypercholesterolemia Khalid Al-Rasadi · Ibrahim Al-Zakwani · Ibrahim Al-Zakwani
Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient—A case report Elinor V. Hanna · Sara Simonelli · Sarah Chamney · Alice Ossoli · Robert N. Mullan · Robert N. Mullan
Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort Jeffrey L. Probstfield · William E. Boden · Todd Anderson · Kelley R. Branch · Moti L. Kashyap · Jerome L. Fleg · Patrice Desvigne-Nickens · Ruth McBride · Mark E. McGovern · Mark E. McGovern
Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size Sotirios Tsimikas · Sergio Fazio · Nicholas J. Viney · Shuting Xia · Joseph L. Witztum · Santica M. Marcovina · Santica M. Marcovina
MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue Emilie Capel · Camille Vatier · Pascale Cervera · Tanya Stojkovic · Emmanuel Disse · Anne-Ségolène Cottereau · Martine Auclair · Marie-Christine Verpont · Héléna Mosbah · Pierre Gourdy · Sara Barraud · A. Miquel · Stephan Züchner · Amélie Bonnefond · Philippe Froguel · Sophie Christin-Maitre · B. Delemer · Bruno Fève · M. Laville · Juliette Robert · Florence Tenenbaum · O. Lascols · Corinne Vigouroux · Isabelle Jéru · Isabelle Jéru
From the editor: O Canada! A tariff-free zone for scientific exchange John R. Guyton · John R. Guyton
PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease Vera Bittner · Robert P. Giugliano · Eliot A. Brinton · John R. Guyton · John R. Guyton
Task-sharing interventions for cardiovascular risk reduction and lipid outcomes in low- and middle-income countries: A systematic review and meta-analysis T.N. Anand · Linju M. Joseph · A.V. Geetha · Joyita Chowdhury · Dorairaj Prabhakaran · Panniyammakal Jeemon · Panniyammakal Jeemon
Differential effects of restrictive and malabsorptive bariatric surgery procedures on the serum lipidome in obese subjects Bruno Ramos-Molina · Bruno Ramos-Molina · Daniel Castellano-Castillo · Daniel Castellano-Castillo · Juan Alcaide-Torres · Juan Alcaide-Torres · Óscar Pastor · Resi de Luna Díaz · Jordi Salas-Salvadó · Jordi Salas-Salvadó · Javier Lopez-Moreno · Javier Lopez-Moreno · José Carlos Fernández-García · José Carlos Fernández-García · Manuel Macías-González · Manuel Macías-González · Fernando Cardona · Fernando Cardona · Francisco J. Tinahones · Francisco J. Tinahones · Francisco J. Tinahones
Metabolic syndrome and its components as risk factors for prolonged corrected QT interval in apparently healthy Korean men and women Byoung-Jin Park · Yong-Jae Lee · Yong-Jae Lee · Yong-Jae Lee
The clinical importance of recognizing capecitabine-induced hypertriglyceridemia: A case report and review of the literature Jenny Leung · Jessica Louise Brady · Martin A. Crook · Martin A. Crook
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society María José Ariza · J. Rioja · Daiana Ibarretxe · Ana Camacho · José Luis Díaz-Díaz · Alipio Mangas · Julio A. Carbayo-Herencia · Pablo Ruiz-Ocaña · Itziar Lamiquiz-Moneo · Daniel Mosquera · Pedro Saenz · Luis Masana · Ovidio Muñiz-Grijalvo · Sofía Pérez-Calahorra · Pedro Valdivielso · M. Suárez Tembra · Gonzalo Pías Iglesias · J.A. Carbayo Herencia · C. Guerrero Buitrago · L. Vila · C. Morales Coca · E. Llargués Rocabruna · V. Perea Castillo · J. Pedro-Botet · E. Climent · M. Mauri Pont · X. Pinto · E. Ortega Martínez de la Victoria · J. Amor · D. Zambón Rados · F. Blanco Vaca · J.M. Ramiro Lozano · F.J. Fuentes Jiménez · I. Soler · C. Ferrer · A. Zamora Cervantes · A. Vila Belmonte · F.J. Novoa Mogollón · R.M. Sanchez-Hernández · A.B. Expósito Montesdeoca · M.J. Romero Jiménez · M.P. González García · M. Bueno Díez · A. Brea Hernando · C. Lahoz · J. Mostaza Prieto · J. Millán Núñez-Cortés · L. Reinares García · A. Blanco Echevarría · María José Ariza Corbo · J. Rioja Villodres · M.A. Sánchez-Chaparro · S. Jansen Chaparro · P. Sáenz Aranzubía · E. Martorell Mateu · F. Almagro Múgica · O. Muñiz Grijalvo · L. Masana Martín · N. Plana Gil · D. Ibarretxe Gerediaga · C. Rodríguez Borjabad · S. Zabala López · A. Hernández Mijares · J.F. Ascaso Gimilio · L. Pérez García · F. Civeira Murillo · S. Pérez-Calahorra · I. Lamiquiz-Moneo · R. Mateo Gallego · V. Marco Benedí · J. Ferrando Vela · J. Ferrando Vela
The value of incorporating medical nutrition therapy by a registered dietitian nutritionist in clinical practice Katherine S. Rhodes · Carol Kirkpatrick · Carol Kirkpatrick
Identification of a functional FADS1 3′UTR variant associated with erythrocyte n-6 polyunsaturated fatty acids levels Xavier Hermant · Charlotte Delay · Amandine Flaig · Jimena Luque-Bedregal · Gilbert Briand · Marie-Adélaïde Bout · Dominique Cottel · Aline Wagner · Dominique Arveiler · Chantal Simon · Jean Ferrières · Jean-Bernard Ruidavets · Brigitte Laillet · Philippe Amouyel · Jean Dallongeville · Aline Meirhaeghe · Julie Dumont · Julie Dumont
Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial Verena Schwetz · Hubert Scharnagl · Christian Trummer · Tatjana Stojakovic · Marlene Pandis · Martin R. Grübler · Nicolas Verheyen · Martin Gaksch · Armin Zittermann · Felix Aberer · Elisabeth Lerchbaum · Barbara Obermayer-Pietsch · Thomas R. Pieber · Winfried März · Andreas Tomaschitz · Stefan Pilz · Stefan Pilz
Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor use in the management of resistant hypercholesterolemia induced by mitotane treatment for adrenocortical cancer Efthymia D. Tsakiridou · Evangelos N. Liberopoulos · Zoe Giotaki · Stelios Tigas · Stelios Tigas
Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH Kirsten B. Holven · Kirsten B. Holven · Ingunn Narverud · Ingunn Narverud · Jeanine Roeters van Lennep · Jorie Versmissen · Linn K.L. Øyri · Annette Galema-Boers · Gisle Langslet · Stine M. Ulven · Marit B. Veierød · Kjetil Retterstøl · Kjetil Retterstøl · Martin P. Bogsrud · Martin P. Bogsrud
Screening of LDLR and APOB gene mutations in Mexican patients with homozygous familial hypercholesterolemia Teresita De Jesús Hernández Flores · Teresita De Jesús Hernández Flores · Juan Ramón González García · Ana Gabriela Colima Fausto · Ana Gabriela Colima Fausto · Norma Alejandra Vázquez Cárdenas · Yoaly Sánchez López · Yoaly Sánchez López · César Augusto Zarate Morales · María Teresa Magaña Torres · María Teresa Magaña Torres · María Teresa Magaña Torres
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study William S. Harris · Nathan L. Tintle · Mark R. Etherton · Mark R. Etherton
Poor attainment of lipid targets in patients with symptomatic peripheral artery disease Jörn F. Dopheide · Lucija Papac · Marc Schindewolf · Iris Baumgartner · Heinz Drexel · Heinz Drexel
Selective prescribing of statins and the risk of mortality, hospitalizations, and falls in aged care services Maarit Jaana Korhonen · Maarit Jaana Korhonen · Jenni Ilomäki · Janet K. Sluggett · Janet K. Sluggett · M. Alan Brookhart · Renuka Visvanathan · Tina Cooper · Leonie Robson · J. Simon Bell · J. Simon Bell
Apolipoprotein B measurement: Need for standardization John H. Contois · Vincent Delatour · Vincent Delatour
Relationship betweenLDL-C, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide Nicholas J. Viney · Calvin Yeang · Xiaohong Yang · Shuting Xia · Joseph L. Witztum · Sotirios Tsimikas · Sotirios Tsimikas
Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue Wieneke Dijk · Sophie Schutte · Edo O. Aarts · Ignace Janssen · Lydia A. Afman · Sander Kersten · Sander Kersten
Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management William Virgil Brown · Ira J. Goldberg · Barton P. Duell · Daniel Gaudet · Daniel Gaudet
Elevated Lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease Simone L. Verweij · Maurice W.J. de Ronde · Rutger Verbeek · S. Matthijs Boekholdt · R. Nils Planken · Erik S.G. Stroes · Sara-Joan Pinto-Sietsma · Sara-Joan Pinto-Sietsma
Predictors of a successful statin reattempt after an adverse reaction Huabing Zhang · Huabing Zhang · Jorge Plutzky · Wendong Ge · Wendong Ge · Maria Shubina · Alexander Turchin · Alexander Turchin
Alirocumab in high-risk patients: Observations from the open-label expanded use program Charles J. Glueck · Alan S. Brown · Anne C. Goldberg · James M. McKenney · Louis Kantaros · John Stewart · Joseph Elassal · Andrew Koren · Andrew Koren
Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP M. John Chapman · M. John Chapman · Alexina Orsoni · Paul Robillard · Patrice Therond · Patrice Therond
Effect of cholesterol lowering with statins or proprotein convertase subtilisin/kexin type 9 antibodies on cataracts: A meta-analysis Jeanne M. Dobrzynski · John B. Kostis · Davit Sargsyan · Stavros Zinonos · William J. Kostis · William J. Kostis
Improved endothelial function after short-term therapy with evolocumab Guglielmo Maulucci · Francesco Cipriani · Dolores Russo · Grazia Casavecchia · Carlo Di Staso · Luigi Di Martino · Antonio Ruggiero · Matteo Di Biase · Natale Daniele Brunetti · Natale Daniele Brunetti
The CKD plasma lipidome varies with disease severity and outcome Flore Duranton · Jonas Laget · Nathalie Gayrard · Jean-Sébastien Saulnier-Blache · Jean-Sébastien Saulnier-Blache · Ulrika Lundin · Joost P. Schanstra · Joost P. Schanstra · Harald Mischak · Klaus M. Weinberger · Marie-Françoise Servel · Àngel Argilés · Àngel Argilés
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members Amy Zawacki · Ann Dodge · Kaitlin M. Woo · J. Carter Ralphe · Amy L. Peterson · Amy L. Peterson
Retinal microvascular dysfunction in hypercholesterolemia Matthias P. Nägele · Jens Barthelmes · Valeria Ludovici · Valeria Ludovici · Silviya Cantatore · Michelle Frank · Frank Ruschitzka · Andreas J. Flammer · Isabella Sudano · Isabella Sudano
The spectrum of type III hyperlipoproteinemia Allan D. Sniderman · Jacqueline de Graaf · George Thanassoulis · André J. Tremblay · Seth S. Martin · Patrick Couture · Patrick Couture
Severe hypertriglyceridemia is primarily polygenic Jacqueline S. Dron · Jian Wang · Henian Cao · Adam D. McIntyre · Michael A. Iacocca · Jyler R. Menard · Irina Movsesyan · Mary J. Malloy · Clive R. Pullinger · John P. Kane · Robert A. Hegele · Robert A. Hegele
Predictors of Statin Use among Older Adults: A Nationwide Cross-Sectional Study Richard Ofori-Asenso · Jenni Ilomäki · Mark Tacey · Ella Zomer · Andrea J. Curtis · J. Simon Bell · J. Simon Bell · Sophia Zoungas · Danny Liew · Danny Liew
Coronary computed tomography angiogram in familial hypercholesterolemia; A double edge sword Sam Mirzaee · James D. Cameron · James D. Cameron
JCL roundtable: High-density lipoprotein function and reverse cholesterol transport Marina Cuchel · Anand Rohatgi · Frank M. Sacks · John R. Guyton · John R. Guyton
Post-prandial lipid absorption in seven heterozygous carriers of deleterious variants of MTTP in two abetalipoproteinemic families Mathilde Di Filippo · Mathilde Varret · Vanessa Boehm · Jean-Pierre Rabès · Jean-Pierre Rabès · Latifa Ferkdadji · Laurent Abramowitz · Sabrina Dumont · Catherine Lenaerts · Catherine Boileau · Francisca Joly · Jacques Schmitz · Marie-Elisabeth Samson Bouma · Dominique Bonnefont-Rousselot · Dominique Bonnefont-Rousselot
Response to letter entitledCoronary computed tomography angiogram in familial hypercholesterolemia; A double edge swordby Dr. Sam Mirzaee and Dr. James D Cameron Leopoldo Pérez de Isla · Rodrigo Alonso · Pedro Mata · Pedro Mata
New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia Marine Dancer · Mathilde Di Filippo · Oriane Marmontel · René Valéro · Maria Del Carmen Piombo Rivarola · N. Peretti · Cyrielle Caussy · M. Krempf · Bruno Vergès · Murielle Mahl · Christophe Marçais · Philippe Moulin · Sybil Charrière · Sybil Charrière
GPIHBP1 autoantibody syndrome during interferon β1a treatment Jun Eguchi · Kazuya Miyashita · Isamu Fukamachi · Katsuyuki Nakajima · Masami Murakami · Yuko Kawahara · Toru Yamashita · Yasuyuki Ohta · Koji Abe · Atsuko Nakatsuka · Mai Mino · Satoru Takase · Hiroaki Okazaki · Robert A. Hegele · Xuchen Hu · Jun Wada · Stephen G. Young · Anne P. Beigneux · Anne P. Beigneux
Recurrent tendosynovitis as a rare manifestation of a lipid disorder Daniel Wadsack · Horst Sattler · Marcus E. Kleber · Katharina Eirich · Hubert Scharnagl · Günter Fauler · Winfried März · Winfried März · Winfried März · Tanja B. Grammer · Tanja B. Grammer
Low LDL-C and risk of hemorrhagic stroke in Chinese adults Rachel H. Mackey · Rachel H. Mackey
Relationship between erythrocyte phospholipid fatty acid composition and obesity in children and adolescents Jun Tang · Yinkun Yan · Jie Li · Bo Yang · Xiaoyuan Zhao · Yi Wan · Ju-Sheng Zheng · Ju-Sheng Zheng · Jie Mi · Duo Li · Duo Li · Duo Li
Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence Vadzim Chyzhyk · Sarah Kozmic · Alan S. Brown · Lisa Hudgins · Thomas J. Starc · Ashley Deleigh Davila · Thomas C. Blevins · Margaret R. Diffenderfer · Lihong He · Andrew S. Geller · Caitlin Rush · Robert A. Hegele · Ernst J. Schaefer · Ernst J. Schaefer
Decreased GlycA after lifestyle intervention among obese, prediabetic adolescent Latinos Micah L. Olson · Micah L. Olson · Ana Rentería-Mexía · Margery A. Connelly · Sonia Vega-López · Erica G. Soltero · Yolanda P. Konopken · Allison N. Williams · Felipe González Castro · Colleen Keller · Hongwei P. Yang · Michael Todd · Gabriel Q. Shaibi · Gabriel Q. Shaibi · Gabriel Q. Shaibi
Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia Martine Paquette · Sophie Bernard · Isabelle Ruel · David W. Blank · Jacques Genest · Alexis Baass · Alexis Baass
In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction François Moreau · Claire Blanchard · Christophe Perret · Laurent Flet · Frédéric Douane · Eric Frampas · E. Mirallié · Mikaël Croyal · Audrey Aguesse · M. Krempf · Xavier Prieur · Matthieu Pichelin · Bertrand Cariou · Cédric Le May · Cédric Le May
Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients Mark Mitsnefes · Jessica Fitzpatrick · Stephen M. Sozio · Bernard G. Jaar · Michelle M. Estrella · Jose Manuel Monroy-Trujillo · Wujuan Zhang · Kenneth D. R. Setchell · Rulan S. Parekh · Rulan S. Parekh
Biphasic dyslipidemia in a patient with painless thyroiditis Toshio Murase · Akira Takeshita · Sadao Arimoto · Sadao Arimoto
Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention Maximilian Tscharre · Robert Herman · Miklos Rohla · Edita Piackova · Kris G. Vargas · Serdar Farhan · Matthias K. Freynhofer · Thomas W. Weiss · Kurt Huber · Kurt Huber
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study Chau L.B. Ho · Enayet Karim Chowdhury · Monique Breslin · Jenny Doust · Christopher M. Reid · Christopher M. Reid · Lindon M.H. Wing · Mark Nelson · Mark Nelson · Lawrence J. Beilin · Garry L. Jennings · Collin I. Johnston · Graham Macdonald · John Marley · John J. McNeil · Trefor Morgan · Philip Ryan · M. J. West · M. J. West
Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal Michael B. Boffa · Saverio Stranges · Neil Klar · Patrick M. Moriarty · Gerald F. Watts · Gerald F. Watts · Marlys L. Koschinsky · Marlys L. Koschinsky
Integrating lipid screening with ideal cardiovascular health assessment in pediatric settings Piers R. Blackett · Minu George · Don P. Wilson · Don P. Wilson
Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia G. Kees Hovingh · John R. Guyton · Gisle Langslet · Robert Dufour · Marie T. Baccara-Dinet · Chantal Din-Bell · Garen Manvelian · Michel Farnier · Michel Farnier
Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1 Petra El Khoury · Petra El Khoury · Philippe Couvert · Sandy Elbitar · Sandy Elbitar · Youmna Ghaleb · Youmna Ghaleb · Yara Abou-Khalil · Yara Abou-Khalil · Yara Azar · Carine Ayoub · Alexandre Superville · Maryse Guerin · Jean-Pierre Rabès · Mathilde Varret · Catherine Boileau · Catherine Boileau · Selim Jambart · Philippe Giral · Alain Carrié · Wilfried Le Goff · Marianne Abifadel · Marianne Abifadel · Marianne Abifadel
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study Julian C. van Capelleveen · Sang-Rok Lee · Sang-Rok Lee · Rutger Verbeek · John J. P. Kastelein · Nicholas J. Wareham · Erik S.G. Stroes · G. Kees Hovingh · Kay-Tee Khaw · S. Matthijs Boekholdt · Joseph L. Witztum · Sotirios Tsimikas · Sotirios Tsimikas
Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins Debi K. Swertfeger · Sandra Rebholz · Sandra Rebholz · Hailong Li · Amy S. Shah · William Sean Davidson · Long J. Lu · Long J. Lu
Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease Hayato Tada · Masa-aki Kawashiri · Akihiro Nomura · Ryota Teramoto · Kazuyoshi Hosomichi · Atsushi Nohara · Akihiro Inazu · Hiroshi Mabuchi · Atsushi Tajima · Masakazu Yamagishi · Masakazu Yamagishi
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study Jan Oscarsson · Kristina Önnerhag · Ulf Risérus · Mattias Sundén · Lars Johansson · Per-Anders Jansson · Linda Moris · Peter Nilsson · Jan W. Eriksson · Lars Lind · Lars Lind
Circulating oleic acid levels are related to greater risks of cardiovascular events and all-cause mortality: The multi-ethnic study of atherosclerosis Brian T. Steffen · Daniel Duprez · Moyses Szklo · Weihua Guan · Michael Y. Tsai · Michael Y. Tsai
Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease Felipe Vendrame · Leticia Olops · Sara Teresinha Olalla Saad · Fernando Ferreira Costa · Kleber Yotsumoto Fertrin · Kleber Yotsumoto Fertrin · Kleber Yotsumoto Fertrin
The prevalence, awareness, and treatment of lipid abnormalities in Iranian adult: Surveillance of risk factors of noncommunicable diseases in Iran 2016 Zahra Aryan · Negar Mahmoudi · Ali Sheidaei · Shahabeddin Rezaei · Zohreh Mahmoudi · Kimyia Gohari · Nazila Rezaei · Mohammad Javad Hajipour · Mohammad Javad Hajipour · Arezou Dilmaghani-Marand · Farideh Razi · Mahdi Sabooni · Farzad Kompani · Alireza Delavari · Bagher Larijani · Farshad Farzadfar · Farshad Farzadfar
Fibroblast growth factor-23 in patients with homozygous familial hypercholesterolemia Jarrod M. Zamparini · Andrew Immelman · Frederick J. Raal · Frederick J. Raal
Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidation Su-Wei Chang · Su-Wei Chang · Mei-Ling Cheng · Mei-Ling Cheng · Ming-Shi Shiao · Chau-Ting Yeh · Chau-Ting Yeh · Chao-Hung Wang · Chao-Hung Wang · Chun-Ming Fan · Cheng-Tang Chiu · Cheng-Tang Chiu · Ming-Ling Chang · Ming-Ling Chang · Ming-Ling Chang
Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study Aya Hirata · Daisuke Sugiyama · Makoto Watanabe · Akiko Tamakoshi · Hiroyasu Iso · Kazuhiko Kotani · Masahiko Kiyama · Michiko Yamada · Shizukiyo Ishikawa · Yoshitaka Murakami · Katsuyuki Miura · Hirotsugu Ueshima · Tomonori Okamura · Tomonori Okamura
Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) genetics Roelof A.J. Smit · Roelof A.J. Smit · J.W. Jukema · J.W. Jukema · Iris Postmus · Ian Ford · Pieternella Eline Slagboom · Bastiaan T. Heijmans · Saskia le Cessie · S. Trompet · S. Trompet · S. Trompet
Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients Tae Ik Chang · Elani Streja · Melissa Soohoo · Gang Jee Ko · Gang Jee Ko · Connie M. Rhee · Csaba P. Kovesdy · Moti L. Kashyap · Nosratola D. Vaziri · Kamyar Kalantar-Zadeh · Hamid Moradi · Hamid Moradi
Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy Annette M.H. Galema‐Boers · Mattie J. Lenzen · Sophie R. Engelkes · Eric J.G. Sijbrands · Jeanine E. Roeters van Lennep · Jeanine E. Roeters van Lennep
Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults—Sri Lanka Diabetes and Cardiovascular Study in 2005–2006 Prasad Katulanda · Prasad Katulanda · Harsha Anuruddhika Dissanayake · S.D. Neomal De Silva · Gaya Wijeweera Katulanda · Isurujith Kongala Liyanage · Godwin R Constantine · Rezvi Sheriff · David R. Matthews · David R. Matthews
Long-term Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibodies: A Meta-Analysis of 11 Randomized Controlled Trials Jie Bai · Lilin Gong · Qifu Li · Zhihong Wang · Zhihong Wang
Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis Luis Masana · Josefa Girona · Daiana Ibarretxe · Ricardo Rodríguez-Calvo · Roser Rosales · Joan-Carles Vallvé · Cèlia Rodríguez-Borjabad · Montserrat Guardiola · Marina Rodríguez · Sandra Guaita-Esteruelas · Iris Oliva · Neus Martínez-Micaelo · Mercedes Heras · Raimon Ferré · Josep Ribalta · Núria Plana · Núria Plana
TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice Aleksandra Uruska · Dorota Zozulińska-Ziółkiewicz · Pawel Niedzwiecki · Monika Pietrzak · Bogna Wierusz-Wysocka · Bogna Wierusz-Wysocka
Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials Amirhossein Sahebkar · Luis E. Simental-Mendía · Dimitri P. Mikhailidis · Matteo Pirro · Maciej Banach · Maciej Banach · Cesare R. Sirtori · Massimiliano Ruscica · Željko Reiner · Željko Reiner
Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf Khalid Al-Rasadi · Ibrahim Al-Zakwani · Alawi A. Alsheikh-Ali · Wael Almahmeed · Wafa Rashed · Mustafa Ridha · Raul D. Santos · Mohammad Zubaid · Mohammad Zubaid
A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome Martine Paquette · Robert A. Hegele · Guillaume Paré · Alexis Baass · Alexis Baass
Angiopoietin-like protein 4: A therapeutic target for triglycerides and coronary disease? David S. Olshan · Daniel J. Rader · Daniel J. Rader
Association of breastfeeding duration with dyslipidemia in women aged over 20 years: Korea National Health and Nutrition Examination Survey 2010–2014 Sunyoung Cho · Euna Han · Euna Han
Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis Nathan D. Wong · Nathan D. Wong · Yanglu Zhao · Yanglu Zhao · Ruben G.W. Quek · Roger S. Blumenthal · Matthew J. Budoff · Mary Cushman · Parveen K. Garg · Veit Sandfort · Michael Y. Tsai · J. Antonio G. López · J. Antonio G. López
Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia Yu Kataoka · Mariko Harada-Shiba · K. Nakao · Takahiro Nakashima · Shoji Kawakami · Masashi Fujino · Tomoaki Kanaya · Toshiyuki Nagai · Yoshio Tahara · Yasuhide Asaumi · Mika Hori · Masatsune Ogura · Yoichi Goto · Teruo Noguchi · Satoshi Yasuda · Satoshi Yasuda
The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia Martine Paquette · Robert Dufour · Alexis Baass · Alexis Baass
Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia Chang-Min Chung · Chang-Min Chung · Ming-Shyan Lin · Jen-Te Hsu · Ju-Feng Hsiao · Shih-Tai Chang · Shih-Tai Chang · Kuo-Li Pan · Kuo-Li Pan · Chun-Liang Lin · Yu-Sheng Lin · Yu-Sheng Lin · Yu-Sheng Lin
The effect of maximal vs submaximal exertion on postprandial lipid levels in individuals with and without coronary heart disease David M. Aronov · Marina G. Bubnova · Natalia V. Perova · Alexander N. Orekhov · Yuri V. Bobryshev · Yuri V. Bobryshev
Low-density lipoprotein receptor–negative compound heterozygous familial hypercholesterolemia: Two lifetime journeys of lipid-lowering therapy Reyhana Yahya · Monique T. Mulder · Eric J.G. Sijbrands · Eric J.G. Sijbrands · Monique Williams · Monique Williams · Jeanine E. Roeters van Lennep · Jeanine E. Roeters van Lennep · Jeanine E. Roeters van Lennep
Sedentary behavior: Is it time to break up with your chair? Meredith C. Peddie · Ashleigh R. Homer · Stephen P. Fenemor · Tracy L. Perry · Nancy J. Rehrer · C. Murray Skeaff · C. Murray Skeaff
Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements Melinda S. Schaller · Greg J. Zahner · Warren J. Gasper · William S. Harris · Michael S. Conte · Nancy K. Hills · S. Marlene Grenon · S. Marlene Grenon
Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome William F. Hancock-Cerutti · Marie Lhomme · Carolane Dauteuille · Sora Lecocq · M. John Chapman · Daniel J. Rader · Anatol Kontush · Marina Cuchel · Marina Cuchel
Urbanization, mainly rurality, but not altitude is associated with dyslipidemia profiles María Lazo-Porras · Antonio Bernabe-Ortiz · Antonio Bernabe-Ortiz · Renato Quispe · Germán Málaga · Liam Smeeth · Robert H. Gilman · William Checkley · J. Jaime Miranda · J. Jaime Miranda
In Memoriam: James M. Felts, PhD Thomas F. Whayne · Thomas F. Whayne
Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial Radmila Lyubarova · Jennifer G. Robinson · Michael I. Miller · Debra L. Simmons · Ping Xu · Beth L. Abramson · Marshall B. Elam · Todd M. Brown · Ruth McBride · Jerome L. Fleg · Patrice Desvigne-Nickens · Woubeshet Ayenew · William E. Boden · William E. Boden
Mortality reduction in patients treated with intensive lipid therapy vs usual care. Re: Zhao XQ, Phan BA, Davis J et al. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study. J Clin Lipidol. 2016;10(5):1091-1097 Vasilios G. Athyros · Athanasios A. Papageorgiou · Valasia Athyrou · Asterios Karagiannis · Asterios Karagiannis
From the Editor: Using PCSK9 inhibitors in practice William Virgil Brown · William Virgil Brown
Rationale for investigating metformin as a protectant against statin-associated muscle symptoms Ossama Elsaid · Beth A. Taylor · Beth A. Taylor · Amanda L. Zaleski · Amanda L. Zaleski · Gregory A. Panza · Gregory A. Panza · Paul D. Thompson · Paul D. Thompson
Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry Kuan-Rau Chiou · Kuan-Rau Chiou · Min-Ji Charng · Min-Ji Charng · Min-Ji Charng
Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants Brian T. Steffen · Weihua Guan · Alan T. Remaley · James H. Stein · Mathew C. Tattersall · Joel D. Kaufman · Michael Y. Tsai · Michael Y. Tsai
Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention Matthew C. Weiss · Eugenia Gianos · Edward A. Fisher · Arthur Schwartzbard · James Underberg · Howard Weintraub · Howard Weintraub
Current smokers with hyperlipidemia lack elevated preβ1-high-density lipoprotein concentrations Yuki Nagao · Satoshi Hirayama · Mika Kon · Kenta Sasamoto · Masami Sugihara · Akiko Hirayama · Miwa Isshiki · Utako Seino · Osamu Miyazaki · Takashi Miida · Takashi Miida
Statin-associated muscle symptoms—Managing the highly intolerant James M. Backes · Janelle F. Ruisinger · Cheryl A. Gibson · Patrick M. Moriarty · Patrick M. Moriarty
Dyslipidemia, Weight Gain, and Decreased Growth Velocity in a 14-Year-Old Male Don P. Wilson · Luke Hamilton · Sameer Prakash · Fernando J. Castro-Silva · James Friedman · James Friedman
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing Angelo B. Cefalù · Rossella Spina · Davide Noto · Valeria Ingrassia · Vincenza Valenti · Antonina Giammanco · Francesca Fayer · Gabriella Misiano · Gianfranco Cocorullo · C. Scrimali · Ornella Palesano · G.I. Altieri · Antonina Ganci · Carlo M. Barbagallo · Maurizio Averna · Maurizio Averna
The association between dietary cholesterol intake and subclinical atherosclerosis in Korean adults: The Kangbuk Samsung Health Study Eun-Jung Rhee · Seungho Ryu · Jong-Young Lee · Sung Ho Lee · EunSun Cheong · Se Eun Park · Cheol-Young Park · Yu Sam Won · Joon Mo Kim · Dong-sik Cho · Hye-Kyung Chung · Ki Chul Sung · Ki Chul Sung
Lysosomal acid lipase deficiency in all siblings of the same parents James J. Maciejko · Premchand Anne · Saleem Raza · Hernando Lyons · Hernando Lyons
Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia Antonio J. Amor · Montserrat Pinyol · Elsa Solà · Marta Catalan · Montserrat Cofán · Zoe Herreras · Nuria Amigó · Rosa Gilabert · Aleix Sala-Vila · Emilio Ros · Emilio Ortega · Emilio Ortega
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy Charlotte Koopal · A. David Marais · Jan Westerink · Frank L.J. Visseren · Frank L.J. Visseren
Mutation-negative familial hypercholesterolemia-When negative is positive Michael D. Shapiro · Michael D. Shapiro
Dietary carbohydrate and fat intakes are differentially associated with lipid abnormalities in Korean adults Su Jin Song · Won O. Song · YoonJu Song · YoonJu Song
Apolipoprotein B vs non–high-density lipoprotein cholesterol: Association with endothelial hemostatic markers and carotid intima-media thickness David Karasek · Helena Vaverkova · Lubica Cibickova · Jaromira Gajdova · Veronika Kubickova · Veronika Kubickova
Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels Harold E. Bays · Peter Sartipy · Peter Sartipy · John Xu · Carl David Sjöström · James Underberg · James Underberg
Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3–acid ethyl esters with an Advanced Lipid TechnologiesTM (ALT®)–based formulation Miguel Lopez-Toledano · Thorsteinn Thorsteinsson · Ahmed Daak · Kevin C. Maki · Colleen Johns · Adrian Rabinowicz · Frederick Sancilio · Frederick Sancilio
Lipid profile, the world needs to change Carlos Eduardo dos Santos Ferreira · Marileia Scartezini · Carolina Nunes França · Carolina Nunes França
Low levels of ApoA1 improve risk prediction of type 2 diabetes mellitus Xing Wu · Zhexin Yu · Wen Su · Daniel Isquith · Moni B. Neradilek · Ning Lu · Fusheng Gu · Hongwei Li · Xue-Qiao Zhao · Xue-Qiao Zhao
Cardiovascular disease prevalence and insulin resistance in the Kyushu–Okinawa Population Study and the Framingham Offspring Study Hiroaki Ikezaki · Hiroaki Ikezaki · Masumi Ai · Ernst J. Schaefer · Seiko Otokozawa · Bela F. Asztalos · Katsuyuki Nakajima · Yanhua Zhou · Ching-Ti Liu · Paul F. Jacques · L. Adrienne Cupples · Norihiro Furusyo · Norihiro Furusyo
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing Andrew D. Laurie · Campbell Kyle · Campbell Kyle
Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system Jove Graham · Robert Sanchez · Joseph J. Saseen · Usha G. Mallya · Mary Panaccio · Michael Evans · Michael Evans
The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes Mehri Jamilian · Mansooreh Samimi · Faraneh Afshar Ebrahimi · Teibeh Hashemi · Mohsen Taghizadeh · Maryamalsadat Razavi · Marzieh Sanami · Zatollah Asemi · Zatollah Asemi
Cardiovascular disease leads to a new algorithm for diabetes treatment Valentina Rodriguez · Matthew C. Weiss · Howard Weintraub · Ira J. Goldberg · Arthur Schwartzbard · Arthur Schwartzbard
The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia Martine Paquette · Michael Chong · Yascara Grisel Luna Saavedra · Guillaume Paré · Robert Dufour · Alexis Baass · Alexis Baass
High density lipoproteins and adrenal steroidogenesis: A population-based study Edward Buitenwerf · Michiel N. Kerstens · Thera P. Links · Ido P. Kema · Robin P. F. Dullaart · Robin P. F. Dullaart
Association of fasting triglyceride concentration and postprandial triglyceride response with the carotid intima-media thickness in the middle aged: The Netherlands Epidemiology of Obesity study Tim Christen · Renée de Mutsert · Karin B. Gast · Patrick C. N. Rensen · Eelco J.P. de Koning · Frits R. Rosendaal · S. Trompet · J. Wouter Jukema · J. Wouter Jukema
Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages Luka Suzuki · Satoshi Hirayama · Mariko Fukui · Makoto Sasaki · Sadayuki Hiroi · Makoto Ayaori · Shuji Terai · Minoru Tozuka · Hirotaka Watada · Takashi Miida · Takashi Miida
Severe decrease in high-density lipoprotein cholesterol with the combination of fibrates and ezetimibe: A case series Estelle Nobécourt · Bertrand Cariou · Gilles Lambert · M. Krempf · M. Krempf
Is it time to get serious about cholesterol screening Don P. Wilson · Don P. Wilson
JCL roundtable: Managing lipid disorders in patients with HIV W. Virgil Brown · Judith A. Aberg · Karen E. Aspry · Chris T. Longenecker · Merle Myerson · Merle Myerson
Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries Raul D. Santos · Mafalda Bourbon · Rodrigo Alonso · Ada Cuevas · Norma Alexandra Vasques-Cardenas · Alexandre C. Pereira · Alonso Merchan · A.C. Alves · Ana Margarida Medeiros · Cinthia E. Jannes · José Eduardo Krieger · Laura Schreier · Leopoldo Pérez de Isla · María Teresa Magaña-Torres · Mario Stoll · Nelva Mata · Nicolás Dell’Oca · Pablo Corral · Sylvia Asenjo · Virginia Bañares · X. Reyes · Pedro Mata · Pedro Mata
Soy protein: Point Mark Messina · Mark Messina
Counterpoint: Soy protein David Jenkins · David Jenkins
Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration Eric Wanneh · Grisel Luna · Robert Dufour · Alexis Baass · Alexis Baass
Relationship between changes in polyunsaturated fatty acids and aging-related arterial stiffness in overweight subjects 50 years or older over a 3-year period Seung Han Baek · Minkyung Kim · Minjoo Kim · Hye Jin Yoo · Ayoung Lee · Minjae Ji · Min Song · Jong Ho Lee · Jong Ho Lee
Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure Lorenz Koller · Bernhard Richter · Max-Paul Winter · Patrick Sulzgruber · Christos Potolidis · Florian Liebhart · Deddo Mörtl · Rudolf Berger · Georg Goliasch · Irene Lang · Johann Wojta · Martin Hülsmann · Alexander Niessner · Alexander Niessner
Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease—four new pediatric cases Pierre Poinsot · Sophie Collardeau Frachon · Lioara Restier · André Sérusclat · Mathilde Di Filippo · Sybil Charrière · Philippe Moulin · Alain Lachaux · Noël Peretti · Noël Peretti
Heterozygous familial hypercholesterolemia presenting as chylomicronemia syndrome Robert S. Rosenson · Sherwin D. Najera · Robert A. Hegele · Robert A. Hegele
Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome Richard M. Turner · Peng Yin · Anita Hanson · Richard J. FitzGerald · Andrew P. Morris · Rod Stables · Andrea Jorgensen · Munir Pirmohamed · Munir Pirmohamed
The effects of statins on exercise and physical activity Adam Noyes · Paul D. Thompson · Paul D. Thompson
Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients Meng Wang · James P. Corsetti · Scott McNitt · David Q. Rich · Charles E. Sparks · Arthur J. Moss · Wojciech Zareba · Wojciech Zareba
Estrogen-associated severe hypertriglyceridemia with pancreatitis Sumayah Aljenedil · Robert A. Hegele · Jacques Genest · Zuhier Awan · Zuhier Awan · Zuhier Awan
The association of the blood lead level and serum lipid concentrations may be modified by the genetic combination of the metallothionein 2A polymorphisms rs10636 GC and rs28366003 AA Chen-Cheng Yang · Chih-Shien Chuang · Chia-I Lin · Chao-Ling Wang · Yung-Cheng Huang · Hung-Yi Chuang · Hung-Yi Chuang · Hung-Yi Chuang
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia Pablo Lázaro · Leopoldo Pérez de Isla · Gerald F. Watts · Rodrigo Alonso · Richard Norman · Ovidio Muñiz · Francisco Fuentes · Francisco Fuentes · Nelva Mata · Jose Lopez-Miranda · José Ramón González-Juanatey · José Luis Díaz-Díaz · Antonio Javier Blasco · Pedro Mata · Pedro Mata
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia John J. P. Kastelein · G. Kees Hovingh · Gisle Langslet · Marie T. Baccara-Dinet · Daniel A. Gipe · Umesh Chaudhari · Jian Zhao · Pascal Minini · Michel Farnier · Michel Farnier
Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions Saulo Mendoza · Olgica Trenchevska · Sarah M. King · Randall W. Nelson · Dobrin Nedelkov · Ronald M. Krauss · Hussein N. Yassine · Hussein N. Yassine
Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy Ranganath Muniyappa · Brent S. Abel · Asha Asthana · Mary Walter · Elaine Cochran · Alan T. Remaley · Monica C. Skarulis · Phillip Gorden · Rebecca J. Brown · Rebecca J. Brown
Questions to the article by Boyer et al Danyan Xu · Jingyuan Chen · Chenlu Wu · Yuan Guo · Yajun Gui · Yajun Gui
Variability in low density lipoprotein-cholesterol concentrations after alirocumab injection Ahmed Elfar · Paul D. Thompson · Paul D. Thompson
Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia? Joana Rita Chora · A.C. Alves · Ana Margarida Medeiros · Cibelle Mariano · Goreti Lobarinhas · António Guerra · Helena Mansilha · Helena Cortez-Pinto · Mafalda Bourbon · Mafalda Bourbon
Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study Graciela Delgado · Bernhard K. Krämer · Stefan Lorkowski · Winfried März · Winfried März · Winfried März · Clemens von Schacky · Marcus E. Kleber · Marcus E. Kleber · Marcus E. Kleber
Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices Samantha K. Sliwinski · Holly C. Gooding · Sarah D. de Ferranti · Thomas I. Mackie · Supriya Shah · Tully Saunders · Laurel K. Leslie · Laurel K. Leslie
Rapidly progressive atherosclerosis after domino liver transplantation from a teenage donor with homozygous familial hypercholesterolemia Jessica R. Golbus · Linda Farhat · Robert J. Fontana · Melvyn Rubenfire · Melvyn Rubenfire
Caveolin 3 deficiency myopathy associated with dyslipidemia: Treatment challenges and possible pathophysiological association Daiana Ibarretxe · Joan Pellejà · Nicolau Ortiz · Luis Masana · Luis Masana
Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps Kevin C. Maki · Orsolya M. Palacios · Marjorie Bell · Peter P. Toth · Peter P. Toth
Influence of sedentary behavior, physical activity, and cardiorespiratory fitness on the atherogenic index of plasma Meghan K. Edwards · Michael J. Blaha · Paul D. Loprinzi · Paul D. Loprinzi
Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE Martine Paquette · Diane Brisson · Robert Dufour · Etienne Khoury · Daniel Gaudet · Alexis Baass · Alexis Baass
β3-Adrenergic receptor regulates hepatic apolipoprotein A-I gene expression Xiaojing Cao · Yanfang Li · Yanfang Li
The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis Serban M. Maierean · Maria-Corina Serban · Amirhossein Sahebkar · Amirhossein Sahebkar · Sorin Ursoniu · Alexandru Serban · Peter Penson · Maciej Banach · Maciej Banach · Maciej Banach · Maciej Banach
Low levels of apolipoprotein-CII in normotriglyceridemic patients with very premature coronary artery disease: Observations from the MISSION! Intervention study Maaike Hermans · Mathijs C. Bodde · J. Wouter Jukema · Martin J. Schalij · Arnoud van der Laarse · Christa M. Cobbaert · Christa M. Cobbaert
A case of severe acquired hypertriglyceridemia in a 7-year-old girl Jessica S. Lilley · MacRae F. Linton · Jennifer C. Kelley · T. Brent Graham · Sergio Fazio · Hagai Tavori · Hagai Tavori
Postprandial triglyceride responses and endothelial function in prediabetic first-degree relatives of patients with diabetes Srivenkata Madhu · Bineet Sinha · Mohammad Aslam · Gopesh Mehrotra · Shridhar Dwivedi · Shridhar Dwivedi · Shridhar Dwivedi
Kefir drink causes a significant yet similar improvement in serum lipid profile, compared with low-fat milk, in a dairy-rich diet in overweight or obese premenopausal women: A randomized controlled trial Yasamin Fathi · Naeimeh Ghodrati · Mohammad-Javad Zibaeenezhad · Shiva Faghih · Shiva Faghih
Genetic Effects on Efficacy of Lipid Lowering Drugs William Virgil Brown · Alan S. Brown · Brian A. Ference · Peter P. Toth · James Underberg · James Underberg
Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia Xiaoyuan Dai Perrard · Zeqin Lian · George Bobotas · Mary R. Dicklin · Kevin C. Maki · Huaizhu Wu · Huaizhu Wu
Niacin and heart disease prevention: Engraving its tombstone is a mistake Harold Robert Superko · Xue-Qiao Zhao · Howard N. Hodis · John R. Guyton · John R. Guyton
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses Toshio Murase · Minoru Okubo · Tetsu Ebara · Yasumichi Mori · Yasumichi Mori
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275) Daniel E. Nixon · Ronald J. Bosch · Ellen S. Chan · Nicholas T. Funderburg · Sally Hodder · Jordan E. Lake · Michael M. Lederman · Karin L. Klingman · Judith A. Aberg · Katherine Bergstrom · Linda Boone · Laurie Myers · Debra Meres · Katherine Shin · Francesca T. Aweeka · Karen Cavanagh · Kathleen Medvik · Laura Hovind · Karl Shaw · Amanda Zadzilla · Amanda Zadzilla
ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans Valérie Lamantia · Valérie Lamantia · Simon Bissonnette · Simon Bissonnette · Hanny Wassef · Yannick Cyr · Yannick Cyr · Alexis Baass · Robert Dufour · Rémi Rabasa-Lhoret · Rémi Rabasa-Lhoret · May Faraj · May Faraj · May Faraj
Detecting familial hypercholesterolemia: The Jack and the Beanstalk principle Andrew C. R. Martin · Charlotte Allen · Jing Pang · Jing Pang · Gerald F. Watts · Gerald F. Watts · Gerald F. Watts
Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function Kyong Yeun Jung · Hwa Young Ahn · Sun Kyoung Han · Young Joo Park · Bo Youn Cho · Min Kyong Moon · Min Kyong Moon · Min Kyong Moon
From the Editor: New guidelines are coming William Virgil Brown · William Virgil Brown
Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease Sandra N Ofori · Sotonye Dodiyi-Manuel · Maclean Rumokere Akpa · Maclean Rumokere Akpa
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial Shun Ishibashi · Hidenori Arai · Koutaro Yokote · Eiichi Araki · Hideki Suganami · Shizuya Yamashita · Shizuya Yamashita
Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis Luis E. Simental-Mendía · Antonio M. Gotto · Stephen L. Atkin · Maciej Banach · Maciej Banach · Matteo Pirro · Amirhossein Sahebkar · Amirhossein Sahebkar
Higher triglyceride level predicts hyperuricemia: A prospective study of 6-year follow-up Yuan Zhang · Fengjiang Wei · Chen Chen · Chunyou Cai · Ning Sun · Jianli Tian · Wentao Shi · Miaomiao Zhang · Yong Zang · Jiani Song · Yukun He · Jiayi Feng · Qianqian Zhou · Mengyan Li · Pufei Bai · Shuzhi Feng · Wei-Dong Li · Wei-Dong Li
Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation Yizhe Ma · Yizhe Ma · Yingyun Gong · Yingyun Gong · Abhimanyu Garg · Hongwen Zhou · Hongwen Zhou · Hongwen Zhou
ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols Itziar Lamiquiz-Moneo · Lucía Baila-Rueda · Ana M. Bea · Rocío Mateo-Gallego · Sofía Pérez-Calahorra · Victoria Marco-Benedí · Antonio Martín-Navarro · Emilio Ros · Montserrat Cofán · José Carlos Rodríguez-Rey · Miguel Pocovi · Ana Cenarro · Fernando Civeira · Fernando Civeira
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk Benoit J. Arsenault · Francine Petrides · Fatiha Tabet · Weihang Bao · G. Kees Hovingh · S. Matthijs Boekholdt · Stéphane Ramin-Mangata · Olivier Meilhac · David A. DeMicco · Kerry-Anne Rye · David D. Waters · John J. P. Kastelein · Philip J. Barter · Gilles Lambert · Gilles Lambert
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children Josefa Girona · Cèlia Rodríguez-Borjabad · Daiana Ibarretxe · Mercedes Heras · Núria Amigó · Albert Feliu · Luis Masana · Núria Plana · E. Amigó · P. Andrés · M. Barrio · J.Á. Bilbao · M. Bosch · J.L. Cabedo · J. Calvo · C. Campillo · E. Castejón · G. Castillejo · M. Castro · R. Cliville · E. De Gotardo · V. Domènech · D. Domínguez · M. Escolà · M. Fernández · J. García · R. Girona · E. Guijarro · M.A. Gutiérrez · D. Iglesias · J.M. Salsas · V. Luque · P. Machado · J. Maixé · M. Mallafré · R. Martin · M. Jiménez · R. Monne · S. Morillo · À. Naranjo · C. Pérez · M. Planelles · C. Querol · M.J. Rabadà · A. Remedi · C. Riquelme · N. Rodríguez · L. Rosell · M. Salvado · O. Salvador · A. Santos · N. Sanz · S. Segura · G. Subirana · P. Tarrades · M. Vendrell · M. Vilella · E. Zabala · E. Zabala
Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey Terry A. Jacobson · Abdullah Khan · Kevin C. Maki · Eliot A. Brinton · Jerome D. Cohen · Jerome D. Cohen
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia G. Kees Hovingh · Frederick J. Raal · Ricardo Dent · Claudia Stefanutti · Olivier S. Descamps · Luis Masana · Armando Lira · Ian Bridges · Blai Coll · David R. Sullivan · David R. Sullivan
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway Martin P. Bogsrud · Gisle Langslet · Cecilie Wium · Dan Johansen · Arne Svilaas · Kirsten B. Holven · Kirsten B. Holven · Kirsten B. Holven
Changes in truncal obesity and fat distribution predict arterial health Frank Corrigan · Heval Mohamed Kelli · Devinder S. Dhindsa · Robert E. Heinl · Ibhar Al Mheid · Muhammad Hammadah · Salim Hayek · Salman Sher · Salman Sher · Danny J. Eapen · Greg S. Martin · Greg S. Martin · Arshed A. Quyyumi · Arshed A. Quyyumi · Arshed A. Quyyumi
Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients Cho-Kai Wu · Hao Yuan Tsai · Mao-Yuan M. Su · Yi Fan Wu · Juey-Jen Hwang · Jiunn Lee Lin · Lian-Yu Lin · Jien Jiun Chen · Jien Jiun Chen
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride Paola Sabrina Buonuomo · Claudio Rabacchi · Marina Macchiaiolo · Chiara Trenti · Tommaso Fasano · Patrizia Tarugi · Andrea Bartuli · Stefano Bertolini · Sebastiano Calandra · Sebastiano Calandra
Assessment of arterial stiffness in patients with familial hypercholesterolemia Hayato Tada · Masa-aki Kawashiri · Atsushi Nohara · Akihiro Inazu · Hiroshi Mabuchi · Masakazu Yamagishi · Masakazu Yamagishi
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline John D. Bucheit · Haleigh Helsing · Pramit Nadpara · Salim S. Virani · Dave L. Dixon · Dave L. Dixon
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data Melanie Premstaller · Melanie Perren · Kuebra Koçack · Christian Arranto · Geneviève Favre · Andreas Lohri · Sabine Gerull · Jakob Passweg · Jörg Halter · Anne Leuppi-Taegtmeyer · Anne Leuppi-Taegtmeyer
Safety of statin treatment in children with familial hypercholesterolemia: Filling the gaps Viviane Z. Rocha · Raul D. Santos · Raul D. Santos
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia Joep C. Defesche · Claudia Stefanutti · Gisle Langslet · Paul N. Hopkins · Werner Seiz · Marie T. Baccara-Dinet · Sara Hamon · Poulabi Banerjee · John J. P. Kastelein · John J. P. Kastelein
A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial Handrean Soran · Handrean Soran · Yifen Liu · Safwaan Adam · Safwaan Adam · Tarza Siahmansur · Jan H. Ho · Jan H. Ho · Jonathan Schofield · Jonathan Schofield · See Kwok · See Kwok · Matthew Gittins · Naveed Younis · J. Martin Gibson · Paul N. Durrington · Paul N. Durrington · Martin K. Rutter · Martin K. Rutter
Mendelian randomization analysis of cholesteryl ester transfer protein and subclinical atherosclerosis: A population-based study Tim Christen · Stella Trompet · Raymond Noordam · Lisanne L. Blauw · Karin B. Gast · Patrick C. N. Rensen · Ko Willems van Dijk · Frits R. Rosendaal · Renée de Mutsert · J. Wouter Jukema · J. Wouter Jukema
Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)Rx and IONIS-APO(a)-LRx antisense oligonucleotide clinical trials Santica M. Marcovina · Nicholas J. Viney · Steven G. Hughes · Shuting Xia · Joseph L. Witztum · Sotirios Tsimikas · Sotirios Tsimikas
Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia Aurélie Delacrétaz · Frederik Vandenberghe · Mehdi Gholam-Rezaee · Nuria Saigi Morgui · Anaïs Glatard · Jacques Thonney · Alessandra Solida-Tozzi · Stéphane Kolly · Sylfa Fassassi Gallo · Philipp S. Baumann · Sylvie Berney · Sandrine Valloton Zulauff · Jean-Michel Aubry · Roland Hasler · Karsten Ebbing · Armin von Gunten · Philippe Conus · Chin B. Eap · Chin B. Eap
Apolipoprotein E containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study Yue Qi · Jing Liu · Wei Wang · Miao Wang · Fan Zhao · Jiayi Sun · Jun Liu · Dong Zhao · Dong Zhao
Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome Atefeh Akrami · Farzad Nikaein · Siavash Babajafari · Shiva Faghih · Hassan Yarmohammadi · Hassan Yarmohammadi
Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1 Omar Abdel-Razek · Singh N. Sadananda · Singh N. Sadananda · Xuan Li · Lubomira Cermakova · Jiri Frohlich · Jiri Frohlich · Liam R. Brunham · Liam R. Brunham
Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention Leah M. Wilson · Russell R. Cross · P. Barton Duell · P. Barton Duell
ForewordFrom the Editor John R. Guyton · John R. Guyton
An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum Kazuya Miyashita · Isamu Fukamachi · Manabu Nagao · Tatsuro Ishida · Junji Kobayashi · Tetsuo Machida · Kiyomi Nakajima · Masami Murakami · Anne P. Beigneux · Stephen G. Young · Katsuyuki Nakajima · Katsuyuki Nakajima · Katsuyuki Nakajima
What is sufficient drug therapy for lipoprotein elevations William Virgil Brown · Alan S. Brown · Peter P. Toth · James Underberg · James Underberg
Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia Konstantinos Toutouzas · John Skoumas · Iosif Koutagiar · Georgios Benetos · Nikoletta Pianou · Alexandros Georgakopoulos · Spyros Galanakos · Alexios S. Antonopoulos · Maria Drakopoulou · Evangelos Oikonomou · Pavlos Kafouris · Pavlos Kafouris · Emmanouil Athanasiadis · Marinos Metaxas · George M. Spyrou · Zoi Pallantza · Nikolaos Galiatsatos · Constantina Aggeli · C. Antoniades · Georgia Keramida · Adrien Peters · Constantinos D. Anagnostopoulos · Dimitris Tousoulis · Dimitris Tousoulis
Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity Christian Abendstein Kjellmo · Helen Karlsson · Torunn Kristin Nestvold · Stefan Ljunggren · Karin Cederbrant · Maritha Marcusson-Ståhl · Monica Mathisen · Knut Tore Lappegård · Anders Hovland · Anders Hovland
A case of sitosterolemia misdiagnosed as familial hypercholesterolemia: A 4-year follow-up Wei Wang · Long Jiang · Long Jiang · Pan-Pan Chen · Yue Wu · Peng-Yu Su · Lu-Ya Wang · Lu-Ya Wang
A common variant in ARHGEF10 alters delta-6 desaturase activity and influence susceptibility to hypertriglyceridemia Juan de Toro-Martín · Frédéric Guénard · Iwona Rudkowska · Simone Lemieux · Patrick Couture · Marie-Claude Vohl · Marie-Claude Vohl
Case StudyDyslipidemia, Weight Gain, and Decreased Growth Velocity in a 14-Year-Old Male Luke Hamilton · Don P. Wilson · Sameer Prakash · Fernando J. Castro-Silva · James Friedman · James Friedman
Acute myocardial infarction in a 25-year-old woman with sitosterolemia Ryuki Kawamura · Hitoshi Saiki · Hayato Tada · Akihiro Hata · Akihiro Hata
The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred Eliot A. Brinton · Paul N. Hopkins · Robert A. Hegele · Andrew S. Geller · Eliana Polisecki · Margaret R. Diffenderfer · Ernst J. Schaefer · Ernst J. Schaefer
A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT) Kwang Kon Koh · Chang-Wook Nam · Ting-Hsing Chao · Ming En Liu · Chiung Jen Wu · Dong Soo Kim · Chong Jin Kim · Ivy Li · Jianyong Li · Marie T. Baccara-Dinet · Pi Jung Hsiao · Chern En Chiang · Chern En Chiang
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure Samira Ghoor · Peter Berlyn · Naeem Brey · Naeem Brey
Short-term cooling increases serum angiopoietin-like 4 levels in healthy lean men Kimberly J. Nahon · Geerte Hoeke · Leontine E.H. Bakker · Ingrid M. Jazet · Jimmy F.P. Berbée · Sander Kersten · Patrick C. N. Rensen · Mariëtte R. Boon · Mariëtte R. Boon
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia Martine Paquette · Robert Dufour · Alexis Baass · Alexis Baass
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia Merel L. Hartgers · Joep C. Defesche · Gisle Langslet · Paul N. Hopkins · John J. P. Kastelein · Marie T. Baccara-Dinet · Werner Seiz · Sara Hamon · Poulabi Banerjee · Claudia Stefanutti · Claudia Stefanutti
Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: A systematic review Adnan Younus · Choudhry Humayun · Rameez Ahmad · Oluseye Ogunmoroti · Yugandhar Kandimalla · Muhammad Aziz · Rehan Malik · Aisha Rasool Saand · Cyndi Valdes · Rohan Badlani · Rohan Badlani · Muhammad Amir Younus · Shozab S. Ali · Ye Chen · Ye Chen · Khurram Nasir · Khurram Nasir
Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects Marie Maraninchi · Nadège Padilla · Sophie Béliard · Bruno Berthet · Juan-Patricio Nogueira · Jeanine Dupont-Roussel · Julien Mancini · Audrey Bégu-Le Corroller · Noémie Dubois · Rachel Grangeot · Catherine Mattei · Marion Monclar · Anastasia Calabrese · Carole Guerin · Charles Desmarchelier · Alain Nicolay · Changting Xiao · Patrick Borel · Gary F. Lewis · René Valéro · René Valéro
The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review Roosmarijn F.H. Lemmers · Mandy van Hoek · Aloysius Lieverse · Adrie J. M. Verhoeven · Eric J.G. Sijbrands · Monique T. Mulder · Monique T. Mulder
Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease Moshen Mazidi · Peter Penson · Anna Gluba-Brzózka · Jacek Rysz · Maciej Banach · Maciej Banach · Maciej Banach
Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables Kevin C. Maki · George Bobotas · Mary R. Dicklin · Margie Huebner · William F. Keane · William F. Keane
Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography Yan Ling · Jingjing Jiang · Bingjie Wu · Xin Gao · Xin Gao
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project Carmen García-Gómez · Maria A. Martín-Martínez · Santos Castañeda · Fernando Sanchez-Alonso · Miren Uriarte-Ecenarro · Carlos González-Juanatey · Montserrat Romera-Baures · José Santos-Rey · José Antonio Pinto-Tasende · Estefanía Quesada-Masachs · Jesús Tornero-Molina · Olga Martínez-González · Tatiana Cobo-Ibáñez · Eugenio Chamizo-Carmona · Sara Manrique-Arija · Dolores Fábregas-Canales · Federico Díaz-González · Federico Díaz-González · Javier Llorca · Miguel A. González-Gay · Eugenia Gonzalez de Rábago · Elena Alonso Blanco Morales · J. Carlos Fernández López · Natividad Oreiro Villar · Antonio Atanes Sandoval · Francisco J. Blanco García · Cayetano Alegre De Miquel · María J. González Fernández · Ramón Huguet Codina · Beatriz Yoldi · Mercedes Ramentol · Gabriela Ávila · Sara Marsal Barril · Martina Steiner · Santiago Muñoz · Fernando Gamero · José García Torón · María P. Moreno Gil · Antonio J. Mas · Pilar Espiño · Inmaculada Ros · Mónica Ibañez · Claudia Murillo · José A. Piqueras · Raimon Sanmartí · Horacio Berman · Sonia Cabrera · Virginia Ruiz · Oscar Fontseré Patón · Benjamín Fernández Gutiérrez · Lydia Abasolo · María D. Fábregas · Joan M. Nolla · Miriam García Arias · Jesús A. García Vadillo · Rosario García de Vicuña · Antonio Fernández Nebro · Maria Angeles Belmonte López · Inmaculada Ureña · María V. Irigoyen · Virginia Coret Cagigal · Ruth López González · Daniel Pielfort Garrido · Juana Sampedro Alvarez · Ángel María García Aparicio · Rebeca Belmonte Gómez · Pastora Granados Bautista · Azucena Hernández Sanz · Carmen O. Sánchez González · Javier Bachiller · Antonio Zea · Francisco J. Manero · Fernando Jimenez Zorzo · Eugenio Giménez Ubeda · Jesús Marzo Gracía · Chesús Beltrán Audera · Marta Medrano · Ángela Pecondón · Celia Erausquin · Soledad Ojeda · Juan Carlos Quevedo · Félix Francisco · Carlos Rodríguez Lozano · Jesús Babío Herráez · Francisco J. López Longo · Delia Gerona · Carlos González Fernández · Luis Carreño · Indalecio Monteagudo · Javier del Pino · María Dolores Sánchez González · Alfonso Corrales · María Enriqueta Peiró · José M. Senabre · José C. Rosas · Isabel Rotés · Estefanía Moreno · Alba Erra · Dolors Grado · Javier Calvo · Amalia Rueda · Ingrid Möller · Isabel Rodríguez · Carmen Barbadillo · Enrique Raya · Pilar Morales · Ana Nieto · Inmaculada Jiménez · Cesar magro · Ana Ruibal Escribano · Sergio Ros Expósito · Ginés Sánchez Nievas · Enrique Júdez Navarro · Manuela Sianes Fernández · María Ángeles García Morales · Isabel Labiano Bastero · Gloria García Consuegra · Natalia Palmou · Silvia Martínez Pardo · Manel Pujol · Elena Riera Alonso · Georgina Salvador · Beatriz González Alvarez · Alberto Cantabrana · Sagrario Bustabad · Esmeralda Delgado · Alejandro Muñoz · Sergio Rodríguez Montero · Luis María Jiménez · Javier Rivera Redondo · Teresa González Hernández · Francisco J. González Polo · Raúl Menor Almagro · José M. Moreno · Emilio Giner Serret · Carla Lannuzzelli Barroso · Laura Cebrián Méndez · María Teresa Navío · Cristina Fernández Carballido · Encarnación Pagán · Pablo Mesa del Castillo · Esperanza Naredo · Ana Cruz · Ana Turrión · Isabel Mateo · Julio Sánchez · María Galindo · Javier García González · Eduardo Collantes · Desireé Ruíz · Pilar Font · Gema Bonilla · Antonio López Meseguer · Manuel J. Moreno · Ma José Moreno Martínez · Ma Dolores Beteta Fernández · Luis F. Linares · Mercedes Morcillo · María L. González Gómez · José M. Aramburu · Natalia A. Rivera · Olaia Fernández Berrizbeitia · María Luz García Vivar · Manel Riera · Yolanda María León · Joan Maymó · Miriam Amirall · Silvia Iniesta Escolano · Silvia Sánchez Serrano · María Pilar Lis Bona · Jordi Fiter · Julia Fernández Melón · Luis Espadaler · Olga Maiz · Joaquín Belzunegui · Inmaculada Bañegil · César Díaz · Ramón Valls · Iván Castellví · María Bonet · Estefania Moreno Ruzafa · Jaime Calvo Alen · Trinidad Pérez Sandoval · Eva Revuelta Evrard · Javier R. Godo · Cruz Fernández Espartero · Francisco J. Navarro Blasco · Jose Gonzalez · José A. Miranda-Filloy · José A. Miranda-Filloy
Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials Ibadete Bytyçi · Gani Bajraktari · Deepak L. Bhatt · Charity J. Morgan · Ali Ahmed · Wilbert S. Aronow · Maciej Banach · Maciej Banach · Maciej Banach · Maciej Banach
JCL roundtable: Cardiovascular disease risk reduction in menopausal women William Virgil Brown · Martha Gulati · Gina P. Lundberg · Gina P. Lundberg
Effects of atorvastatin treatment on left ventricular diastolic function in peritoneal dialysis patients—The ALEVENT clinical trial Cho-Kai Wu · Chih-Fan Yeh · Jiun-Yang Chiang · Ting-Tse Lin · Yi-Fan Wu · Chih-Kang Chiang · Tze-Wah Kao · Kuan-Yu Hung · Jenq-Wen Huang · Jenq-Wen Huang
Functional analysis of new 3′ untranslated regions genetic variants in genes associated with genetic hypercholesterolemias Flor M. Pérez-Campo · Isabel De Castro-Orós · Alicia Noriega · Montserrat Cofán · Itziar Lamiquiz-Moneo · Ana Cenarro · Emilio Ros · Fernando Civeira · Miguel Pocovi · José Carlos Rodríguez-Rey · José Carlos Rodríguez-Rey
High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant Jianhui Liu · Kunimasa Yagi · Kunimasa Yagi · Atsushi Nohara · Daisuke Chujo · Azusa Ohbatake · Aya Fujimoto · Yukiko Miyamoto · Junji Kobayashi · Masakazu Yamagishi · Masakazu Yamagishi
Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience Annette M.H. Galema‐Boers · Mattie J. Lenzen · Eric J.G. Sijbrands · Jeanine E. Roeters van Lennep · Jeanine E. Roeters van Lennep
Attitudes and actions: A survey to assess statin use among Finnish patients with increased risk for cardiovascular events Reija Silvennoinen · Juha H. Turunen · Petri T. Kovanen · Mikko Syvänne · Matti J. Tikkanen · Matti J. Tikkanen
The heterozygous N291S mutation in the lipoprotein lipase gene impairs whole-body insulin sensitivity and affects a distinct set of plasma metabolites in humans Sofia Mikkelsen Berg · Sofia Mikkelsen Berg · Jesper Foged Havelund · Harald Hasler-Sheetal · Vibeke Kruse · Andreas James Thestrup Pedersen · Aleksander Bill Hansen · Mads Nybo · Henning Beck-Nielsen · Kurt Højlund · Kurt Højlund · Nils J. Færgeman · Nils J. Færgeman
A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience Anum Saeed · Salim S. Virani · Peter H. Jones · Vijay Nambi · Danièle Zoch · Christie M. Ballantyne · Christie M. Ballantyne
Lipid profile, changes in laboratory prescriptions are necessary Gabriel Lima-Oliveira · Carlos David Valentim · Gian Cesare Guidi · Gian Cesare Guidi
Preliminary spectrum of genetic variants in familial hypercholesterolemia in Argentina Virginia Bañares · Pablo Corral · Ana Margarida Medeiros · Ana Margarida Medeiros · María Beatriz Araujo · Alfredo Lozada · Juan P. Bustamante · Roxana Cerretini · Graciela López · Mafalda Bourbon · Mafalda Bourbon · Laura Schreier · Laura Schreier
Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 Jonathan Edmiston · Nathan Brooks · Hagai Tavori · Jessica Minnier · Bart Duell · Jonathan Q. Purnell · Tina M. Kaufman · Cezary Wójcik · Szilard Voros · Sergio Fazio · Michael D. Shapiro · Michael D. Shapiro
Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia Barbara Sjouke · R. Yahya · Michael W. T. Tanck · Joep C. Defesche · Jacqueline de Graaf · Albert Wiegman · John J. P. Kastelein · Monique Mulder · G. Kees Hovingh · Jeanine E. Roeters van Lennep · Jeanine E. Roeters van Lennep
Relationship of cotinine-verified and self-reported smoking status with metabolic syndrome in 116,094 Korean adults Byung Jin Kim · Ji Min Han · Jung Gyu Kang · Eun-Jung Rhee · Bum Soo Kim · Jin Ho Kang · Jin Ho Kang
From the Editor: Preventing cardiovascular death William Virgil Brown · William Virgil Brown
Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes Nermin Kady · Yuanqing Yan · Tatiana Salazar · Qi Wang · Harshini Chakravarthy · Chao Huang · Eleni Beli · Svetlana Navitskaya · Maria B. Grant · Julia V. Busik · Julia V. Busik
Multiple symmetric lipomatosis and gynecomastia: A case report and relative literature review Meimei Tian · Yan Liu · Zhongji Zhi · Yukun Li · Yukun Li
A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis Jing Cao · Jing Cao · Brian T. Steffen · Weihua Guan · Alan T. Remaley · Joseph P. McConnell · Vikram Palamalai · Vikram Palamalai · Michael Y. Tsai · Michael Y. Tsai
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events David D. Waters · Sripal Bangalore · Rana Fayyad · David A. DeMicco · Rachel Laskey · Shari Melamed · Philip J. Barter · Philip J. Barter
Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals Peiwen Zhang · Chen Yang · Honghui Guo · Jiaji Wang · Shengqiang Lin · Huamei Li · Yan Yang · Wenhua Ling · Wenhua Ling
Prevalence of high cholesterol levels suggestive of familial hypercholesterolemia in Brazilian adolescents: Data from the study of cardiovascular risk in adolescents Tatiana Lorena da Luz Kaestner · Vivian Freitas Rezende Bento · Daiane Cristina Pazin · Cristina Pellegrino Baena · Marcia Olandoski · Gabriela de Azevedo Abreu · Maria Cristina Caetano Kuschnir · Katia Vergetti Bloch · José Rocha Faria-Neto · José Rocha Faria-Neto
Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis George A. Kaysen · Barbara Grimes · Lorien S. Dalrymple · Glenn M. Chertow · Julie H. Ishida · Julie H. Ishida · Cynthia Delgado · Cynthia Delgado · Mark R. Segal · Janet Chiang · Janet Chiang · Tjien Dwyer · Kirsten L. Johansen · Kirsten L. Johansen · Kirsten L. Johansen
A case of apolipoprotein A-I deficiency due to carboxyl-terminal truncation Sho Tanaka · Akira Haketa · Tohru Sakimoto · Masanori Abe · Masanori Abe
Maternal lipid profile 6 years after a gestational hypertensive disorder Laura Benschop · Nienke Bergen · Sarah Timmermans · Vincent W. V. Jaddoe · Monique Mulder · Eric A.P. Steegers · Jeanine E. Roeters van Lennep · Jeanine E. Roeters van Lennep
Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study Katerina K. Naka · Aris Bechlioullis · Aikaterini Marini · Dimitrios Sionis · Konstantinos Vakalis · Georgios Triantis · Leon Wilkins · John J. Rogus · Kenneth S. Kornman · Joseph L. Witztum · Lynn Doucette-Stamm · Lampros K. Michalis · Sotirios Tsimikas · Sotirios Tsimikas
Apolipoprotein A-I: A favorable prognostic marker in infective endocarditis Xue-biao Wei · Xiao-jin Chen · Yuan-ling Li · Jie-leng Huang · Xiao-lan Chen · Dan-qing Yu · Ning Tan · Yuan-hui Liu · Jiyan Chen · Peng-cheng He · Peng-cheng He
From the editor: A run of success in treating atherosclerotic vascular disease John R. Guyton · John R. Guyton
Regular activity breaks combined with physical activity improve postprandial plasma triglyceride, nonesterified fatty acid, and insulin responses in healthy, normal weight adults: A randomized crossover trial Ashleigh R. Homer · Stephen P. Fenemor · Tracy L. Perry · Nancy J. Rehrer · Claire Cameron · C. Murray Skeaff · Meredith C. Peddie · Meredith C. Peddie
Roundtable on etiology of familial chylomicronemia syndrome—Recorded at the National Lipid Association Meeting William Virgil Brown · Daniel Gaudet · Ira J. Goldberg · Rob Hegele · Rob Hegele
Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins Yukiko Hasegawa · Mika Hori · Tomoko Nakagami · Mariko Harada-Shiba · Yasuko Uchigata · Yasuko Uchigata
PCSK9 inhibitor therapy in homozygous familial defective apolipoprotein B-100 due to APOB R3500Q: A case report Lars W. Andersen · Tina Davis · Heidi Testa · Rolf Andersen · Rolf Andersen
Successful treatment of a patient with statin-induced myopathy and myotonic dystrophy type II with proprotein convertase subtilisin/kexin type 9 inhibitor, alirocumab (Praluent) Mohamed K.M. Shakir · Terry Shin · Thanh D. Hoang · Vinh Q. Mai · Vinh Q. Mai
A novel homozygous mutation causing lecithin–cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemia David Rial-Crestelo · Ildefonso Santos-Recuero · Josep Julve · Francisco Blanco-Vaca · Miguel Torralba · Miguel Torralba
Marine omega-3 fatty acids and cardiac death John R. Guyton · John R. Guyton
Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis Robert Wolk · Ehrin J. Armstrong · Peter Riis Hansen · Bruce H. Thiers · Shuping Lan · Anna M. Tallman · Mandeep Kaur · Svitlana Tatulych · Svitlana Tatulych
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis Kamal Awad · Maria-Corina Serban · Peter Penson · Dimitri P. Mikhailidis · Peter P. Toth · Steven R. Jones · Manfredi Rizzo · George Howard · Gregory Y.H. Lip · Maciej Banach · Maciej Banach · Maciej Banach
A Case of HMGCR-Antibodies Causing Statin-Associated Autoimmune Necrotizing Myopathy Ben Brannick · R. Childress · R. Childress
Plasma Eicosapentaenoic Acid (EPA) and EPA/AA (Arachidonic Acid) Ratio in a JELIS (Japan EPA Lipid Intervention Study)-like Cohort: Cause for Alarm? John Nelson · Leigh Alexander · Michael Mehan · Rosalynn Gill · Rosalynn Gill
Trends in Testing for Lipoprotein(a) at an Academic Medical Center Over 13 Years Michael J. Wilkinson · Andrew Huynh · Rawan AlGhawi · Cuibin Jin · Gary Ma · Samhita Palakodeti · Lawrence Ang · Bruno Cotter · Sotirios Tsimikas · Sotirios Tsimikas
Improving Diagnosis of Familial Chylomicronemia: Success of Online CME Jelena Spyropoulos · Joy Marko · Colleen Healy · Colleen Healy
The Effects of Aspirin in Combination with EPA and DHA on HDL Cholesterol and HDL-ApoA-I Exchange in Individuals with Type 2 Diabetes Mellitus Ashley Holub · Amir Abdolahi · Xin Tu · Shaker A. Mousa · Michael Oda · Robert C. Block · Robert C. Block
The Potential of Electronic Health Record Data to Optimize Recruitment Efficiency in Cardiovascular Outcome Trials Gregory A. Nichols · Craig Granowitz · Kristi Reynolds · Sephy Philip · Sergio Fazio · Sergio Fazio
Cost Effective Model for Genomic Screening for Familial Hypercholesterolemia Mutations in Populations With High LDL Cholesterol Levels Robert Fishberg · Qingxuan Song · Zeil Rosenberg · Danielle Zamarelli · Danielle Zamarelli
Treating Hypercholesterolemia with PCSK9 Inhibitors in a Real-World Setting: Twenty Month Experience with Ninety Patients Glenn Huth · Ann Mayer · Jessie Collar · Jessie Collar
Bempedoic Acid Reduces LDL-C and is Well-Tolerated in Patients Receiving Atorvastatin 80 mg Background Therapy Mary McGowan · Diane MacDougall · Jeffrey C. Hanselman · Sharon Watling · Narendra D. Lalwani · Narendra D. Lalwani
Safety and Efficacy of Sebelipase Alfa Administered for 52 Weeks in Four Male Siblings Diagnosed With Lysosomal Acid Lipase Deficiency James J. Maciejko · Hernando Lyons · Premchand Anne · Premchand Anne
Effects of Switching to a Second High Intensity Statin on Low Density Lipoprotein Cholesterol Levels in Clinical Practice in Patients with Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia Navneet Upadhyay · Jeetvan Patel · David J. Harrison · David J. Harrison
Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome Sabry M. Abdeldyem · Tarek Goda · Samy A Khodeir · Sabry Abou Saif · Sherief Abd-Elsalam · Sherief Abd-Elsalam
Increased Prevalence of Clinical and Sub-Clinical Atherosclerosis in Individuals With Damaging Mutations in ABCA1 and APOA1 Omar Abdel-Razek · Singh N. Sadananda · Jiri Frohlich · Liam R. Brunham · Liam R. Brunham
Value of Clinical Decision Support and Limited Dutch Lipid Clinic Network Criteria In the Diagnosis of Familial Hypercholesterolemia and Premature Coronary Artery Disease Wael Eid · Tamuchin McCreless · Tamuchin McCreless
A Patient With Elevated Plasma High Density Lipoprotein (HDL) and Facial Flushing Wenliang Song · Ginger L. Milne · John Fahrenholz · Vineet Agrawal · Daniel Clark · Weijuan Li · John McPherson · John A. Oates · Dan M. Roden · MacRae F. Linton · MacRae F. Linton
Plasma Ceramides Predict Residual Cardiovascular Death Risk in Optimally Statin Treated Patients With Stable Coronary Artery Disease Reijo Laaksonen · Mika Hilvo · Reini Hurme · Ottar Nygård · Ottar Nygård
Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) Trial Attainment of National Lipid Association Guideline (NLA) Goals Tony Mathews · Howard Weintraub · Arthur Schwartzbard · James Underberg · Jonathan D. Newman · Sean P. Heffron · Antoinette Schoenthaler · Edward A. Fisher · Eugenia Gianos · Eugenia Gianos
Causes of Hypercholesterolemia Ernst J. Schaefer · Margaret R. Diffenderfer · Michael Mehan · Michael Mehan
Follow-Up Real-World Data in a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Cohort: Results From a Pharmacist-Run Clinic Matthew Stryker · Joseph Bizier · Michael P. Kane · Michael P. Kane
Protecting the Gains: What Changes are Needed to Prevent a Reversal of the Downward CVD Mortality Trend? Jesse D. Ortendahl · Peter P. Toth · Dasha Cherepanov · Amanda L. Harmon · Michael S. Broder · Allison Diamant · Allison Diamant
The Clinical and Psychosocial Burden of Patients with Familial Chylomicronemia Syndrome Alan S. Brown · Joyce L. Ross · Alan Gilstrap · Andrew Hsieh · Karren Williams · Andres Gelrud · Andres Gelrud
Lipoprotein(a) Levels and Age at Onset of Cardiovascular Disease in Family Members of a Pediatric Familial Hypercholesterolemia Population Amy Zawacki · Amy L. Peterson · Kaitlin M. Woo · Erin Marriott · Ann Dodge · Ann Dodge
Challenges in Interpreting Genetic Reports in Familial Hypercholesterolemia: Variants of Uncertain Significance Masako Ueda · Ezim Ajufo · Kristen Dilzell · Tracey Sikora · Anna Raper · Marina Cuchel · Emil M. deGoma · Daniel J. Rader · Daniel J. Rader
Lipoprotein (a) Does Not Adversely Impact Vascular Health in Children with Dyslipidemia Omar Qayum · Geetha Raghuveer · Chizitam Ibezim · Chizitam Ibezim
HDL-Associated Proteins and LDL Differentially Modulate Chronic Myelogenous Leukemia Cell Viability Catherine J. Andersen · Kristina Murray · Nicholas Ragonesi · Adam Doerr · Layra Cintron-Rivera · Lydia Dupree · Lydia Dupree
Discordance of Low-Density Lipoprotein Cholesterol With Alternate Lipid Measures in Statin-Treated Men and Women With Mixed Dyslipidemia Kevin C. Maki · Mary R. Dicklin · Margie Bell · Michael Davidson · Michael Davidson
Gender Dictates the Relationship Between Clinical Markers of Lipid Metabolism and Immune Function in NHANES 1999-2004 Catherine J. Andersen · Terrence Vance · Terrence Vance
A Comparison of the Attainment of Guideline-Recommended LDL-C Lowering With Statin and Ezetimibe+Statin Therapies Peter P. Toth · Adam B. Polis · Joanne E. Tomassini · Erin Jensen · Michel Farnier · Harold E. Bays · Jianxin Lin · Steve Bird · JoAnne M. Foody · Andrew M. Tershakovec · Andrew M. Tershakovec
Intensive Lifestyle Interventions Improve Isolated Systolic Hypertension Francisco E. Ramirez · Neil Nedley · Neil Nedley
Evaluation of the Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Statin Intolerant Patients of an Outpatient Lipid Clinic Erica Davidson · Melissa Snider · Kelly Bartsch · Andrea Hirsch · John Larry · John Larry
Gene Expression Signature of Platelet Count in Lipoprotein Lipase Deficiency Karine Tremblay · Diane Brisson · Daniel Gaudet · Daniel Gaudet
The Diagnosis and Treatment of Cerebrotendinous Xanthomatosis Ernst J. Schaefer · Gerald Salen · Eliana Polisecki · Florian Eichler · Mary J. Malloy · Patamaporn Patamaport · Andrew S. Geller · Margaret R. Diffenderfer · Taylor Sacco · Michael Mehan · Michael Mehan
Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants Brian T. Steffen · Suzette J. Bielinski · Paul A. Decker · Cecilia Berardi · Cecilia Berardi · Nicholas B. Larson · James S. Pankow · Erin D. Michos · Naomi Q. Hanson · David M. Herrington · Michael Y. Tsai · Michael Y. Tsai
Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune disease Robert E. Heinl · Heather Tennant · John C. Ricketts · Claire R. Rice · Cordelia B. Robinson · Pratik Sandesara · Patrick M. Moriarty · Laurence Sperling · Laurence Sperling
The effect of dietary protein source on serum lipids: Secondary data analysis from a randomized clinical trial Anda R. Gonciulea · Deborah E. Sellmeyer · Deborah E. Sellmeyer
Clinical implications of the American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol for a rural community: Data from the Heart of New Ulm Project Michael D. Miedema · Abbey C. Sidebottom · Arthur Sillah · Gretchen Benson · Thomas Knickelbine · Jeffrey J. VanWormer · Jeffrey J. VanWormer
Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolism Marion Morena · Cédric Le May · Leila Chenine · Lucie Arnaud · Anne-Marie Dupuy · Matthieu Pichelin · Hélène Leray-Moragues · Lotfi Chalabi · Bernard Canaud · Bernard Canaud · Jean-Paul Cristol · Bertrand Cariou · Bertrand Cariou
Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia A. Gallo · A. Gallo · A. Gallo · Philippe Giral · Alain Carrié · Valérie Carreau · Sophie Béliard · Randa Bittar · Marianna Maranghi · Marcello Arca · Philippe Cluzel · Philippe Cluzel · Alban Redheuil · Alban Redheuil · Eric Bruckert · D. Rosenbaum · D. Rosenbaum · D. Rosenbaum · D. Rosenbaum
Cholesterol delivery to the adrenal glands estimated by adrenal venous sampling: An in vivo model to determine the contribution of circulating lipoproteins to steroidogenesis in humans Edward Buitenwerf · Robin P. F. Dullaart · Anneke C. Muller Kobold · Thera P. Links · Wim J. Sluiter · Margery A. Connelly · Michiel N. Kerstens · Michiel N. Kerstens
Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia Martine Paquette · Michael Chong · Sébastien Thériault · Robert Dufour · Guillaume Paré · Alexis Baass · Alexis Baass
Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit G. Kees Hovingh · Anne C. Goldberg · Patrick M. Moriarty · Patrick M. Moriarty
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers Elliot Offman · Michael Davidson · Catarina Nilsson · Catarina Nilsson
Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia Sven Bos · Michael Phillips · Gerald F. Watts · Gerald F. Watts · Adrie J. M. Verhoeven · Eric J.G. Sijbrands · Natalie C. Ward · Natalie C. Ward · Natalie C. Ward
Mortality in the Familial Atherosclerosis Treatment Study-Observational Study Paul Poirier · André Marette · Jean-Pierre Després · Eric Larose · Benoit J. Arsenault · Benoit J. Arsenault
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy Ambika P. Ashraf · Anna C.E. Hurst · Abhimanyu Garg · Abhimanyu Garg
JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1) William Virgil Brown · Yehuda Handelsman · Seth S. Martin · Pamela B. Morris · Pamela B. Morris
From the Editor: The Journal of Clinical Lipidology—2007 to 2017 William Virgil Brown · William Virgil Brown
Can iPCSK9-induced hypocholesterolemia starve cancer cells? Anne Gangloff · Frédéric Calon · Nabil G. Seidah · Nabil G. Seidah
Sitosterolemia: A multifaceted metabolic disorder with important clinical consequences Eleftheria Tzavella · Eleftheria Hatzimichael · Christina Kostara · Eleni Bairaktari · Moses Elisaf · Vasilis Tsimihodimos · Vasilis Tsimihodimos
Arterial function parameters in patients with metabolic syndrome and severe hypertriglyceridemia Egidija Rinkūnienė · Eglė Butkutė · Roma Puronaitė · Žaneta Petrulionienė · Vilma Dženkevičiūtė · Vytautas Kasiulevičius · Aleksandras Laucevičius · Aleksandras Laucevičius
Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients Alex Quinn · Rachel Schwemberger · Eveline Oestreicher Stock · Irina Movsesyan · Andrea L. Axtell · Sunny Chang · Brian Y. Ishida · Mary J. Malloy · John P. Kane · Clive R. Pullinger · Clive R. Pullinger
Short-term cooling increases serum triglycerides and small high-density lipoprotein levels in humans Geerte Hoeke · Kimberly J. Nahon · Leontine E.H. Bakker · Sabine S.C. Norkauer · Donna Lee M. Dinnes · Maaike Kockx · Laeticia Lichtenstein · Diana Drettwan · Anne Reifel-Miller · Tamer Coskun · Philipp Pagel · Fred P.H.T.M. Romijn · Christa M. Cobbaert · Ingrid M. Jazet · Laurent O. Martinez · Leonard Kritharides · Jimmy F.P. Berbée · Mariëtte R. Boon · Patrick C. N. Rensen · Patrick C. N. Rensen
Triglyceride-Lowering Effect of Omega-3 Fatty Acid Ethyl Esters Using Advanced Lipid Technologiestm (ALT®) formulations Under Fasting Conditions Miguel Lopez-Toledano · Ahmed Daak · Thorsteinn Thorsteinsson · Frederick Sancilio · Adrian Rabinowicz · Adrian Rabinowicz
Minimal Food Effect for Eicosapentaenoic Acid and Docosahexaenoic Acid Bioavailability from Omega-3 Acid Ethyl Esters with an ALT based formulation Ahmed Daak · Miguel Lopez-Toledano · Thorsteinn Thorsteinsson · Kevin C. Maki · Colleen Johns · Adrian Rabinowicz · Frederick Sancilio · Frederick Sancilio
Team Approach to Prescribing Success for PCSK9 Inhibitors Tina Davis · Joette Hughes · Joette Hughes
Propofol-Induced Hypertriglyceridemia as a Cause of Stroke Matthew C. Weiss · Matthew C. Weiss
Familial Chylomicronemia Syndrome (FCS) Patients Recruited to the APPROACH Trial of Volanesorsen Therapy are Representative of Subjects with FCS Daniel Gaudet · Dirk Blom · Eric Bruckert · Erik S.G. Stroes · John J. P. Kastelein · John P. Kane · Mary J. Malloy · Philippe Moulin · Kjetil Retterstøl · Steve Hughes · Andres Digenio · Joseph L. Witztum · Sam Tsimikas · Sam Tsimikas
Lipoprotein (a) levels and Risk of Cardiovascular Disease Events in Diabetes Mellitus and Prediabetes: The Atherosclerosis Risk in Communities Study Anum Saeed · Anandita Agarwala · Wensheng Sun · Salim S. Virani · Vijay Nambi · Josef Coresh · Elizabeth Selvin · Eric Boerwinkle · Peter J. H. Jones · Christie M. Ballantyne · Ron C. Hoogeveen · Ron C. Hoogeveen
Interim Results of the Investigation of Findings and Observations Captured in Burden of Illness Survey in FCS Patients (IN-FOCUS): US Respondents Michael Davidson · Michael Stevenson · Andrew Hsieh · Zahid Ahmad · Joseph L. Witztum · Joseph L. Witztum
In)Equity in Primary Prevention Statin Treatment Among Diabetics Christopher Latanich · Shermeen Memon · Sara Sirna · Sara Sirna
Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles Jan W. Balder · Jeroen K. de Vries · Ilja M. Nolte · Peter Lansberg · Jan Albert Kuivenhoven · Pieter Willem Kamphuisen · Pieter Willem Kamphuisen
The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS) Daniel Gaudet · Andres Digenio · Vickie Alexander · Marcello Arca · Alan Jones · Erik S.G. Stroes · Jean Bergeron · Ferdando Civeira · Linda C. Hemphill · Dirk Blom · JoAnn Flaim · Steven G. Hughes · Richard S. Geary · Sotirios Tsimikas · Joseph L. Witztum · Eric Bruckert · Eric Bruckert
A Novel Omega-3-Acid Ethyl Ester formulation Incorporating Advanced Lipid Technologies (ALT®) Improves DHA and EPA bioavailability compared with Lovaza Miguel Lopez-Toledano · Thorsteinn Thorsteinsson · Ahmed Daak · Kevin C. Maki · Colleen Johns · Adrian L. Rabinowicz · Frederick Sancilio · Frederick Sancilio
Improving Lipid Management in Clinical Practice: Effect of Online CME Jelena Spyropoulos · George Boutsalis · George Boutsalis
Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides(200-499mg/dL)on Statin Therapy(EVAPORATE Study): Rationale and Design Matthew J. Budoff · J. Muhlestein · Viet T. Le · Heidi May · John Nelson · Sion K. Roy · Sion K. Roy
Pediatric Atherosclerosis Prevention and Lipidology Group Registry Luke Hamilton · Samuel S. Gidding · Don P. Wilson · Don P. Wilson
PCSK-9i Gender Study Debra Friedrich · Paul E. Ziajka · Sudha Ravilla · John Diaz · Ralph Vicari · Ralph Vicari
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association Carl E. Orringer · Terry A. Jacobson · Joseph J. Saseen · Alan S. Brown · Antonio M. Gotto · Joyce L. Ross · James Underberg · James Underberg
Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association Jerome D. Cohen · Mark J. Cziraky · Terry A. Jacobson · Kevin C. Maki · Dean G. Karalis · Dean G. Karalis
JCL roundtable: Future of the lipid laboratory: Using the laboratory to manage the patient (part 2) William Virgil Brown · Yehuda Handelsman · Seth S. Martin · Pamela B. Morris · Pamela B. Morris
Lipoprotein particle number and size predict vascular structure and function better than traditional lipids in adolescents and young adults Elaine M. Urbina · Connie E McCoy · Zhiqian Gao · Philip R. Khoury · Amy S. Shah · Lawrence M. Dolan · Thomas R. Kimball · Thomas R. Kimball
A case of autosomal recessive hypercholesterolemia responsive to proprotein convertase subtilisin/kexin 9 inhibition Eoin Francis Fahy · Elaine McCarthy · Elisabeth Steinhagen-Thiessen · Carl J. Vaughan · Carl J. Vaughan
High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein Javier Rodríguez-Carrio · Mercedes Alperi-López · Patricia López · Raquel López-Mejías · Sara Alonso-Castro · Francisco Abal · Francisco J. Ballina-García · Miguel A. González-Gay · Miguel A. González-Gay · Ana Suárez · Ana Suárez
Identifying familial hypercholesterolemia in Colombia Juan Manuel Toro · Alejandro Román-González · Carlos Alfonso Builes-Barrera · Carlos Alfonso Builes-Barrera
Firefighters on the East and West Coasts Have Increased CHD Risk Associated With Insulin Resistance and Small LDL H. Robert Superko · Gaudenz Panholzer · Spencer Reade · Brenda Garrett · Casey Snyder · E.J. Schaefer · E.J. Schaefer
Omega-6 fatty acids: Opposing associations with risk—The Ludwigshafen Risk and Cardiovascular Health Study Graciela Delgado · Winfried März · Winfried März · Winfried März · Stefan Lorkowski · Clemens von Schacky · Marcus E. Kleber · Marcus E. Kleber · Marcus E. Kleber
Familial hypercholesterolemia in a European Mediterranean population—Prevalence and clinical data from 2.5 million primary care patients Alberto Zamora · Luis Masana · Marc Comas-Cufí · Àlex Vila · Núria Plana · Maria García-Gil · Lia Alves-Cabratosa · Jaume Marrugat · Irene Roman · Rafel Ramos · Rafel Ramos
Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies Xiaojing Lin · Xiaojing Lin · Lei Lu · Lei Lu · Lingli Liu · Siyu Wei · Yunyun He · Jing Chang · Xuemei Lian · Xuemei Lian · Xuemei Lian
Growth hormone activates hepatic and cerebral cholesterol metabolism in small-for-gestational age children without catch-up growth Satoshi Hirayama · Hironori Nagasaka · Saori Nakagawa · Mayuko Takuwa · Mariko Nakacho · Tohru Yorifuji · Hiroki Kondou · Hirokazu Tsukahara · Ichiro Morioka · Akihito Ishida · Susumu Yamato · Takashi Miida · Takashi Miida
Preventive effect of pravastatin on the development of hypertension in patients with hypercholesterolemia: A post-hoc analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study Toshiaki Otsuka · Kyoichi Mizuno · Tomohiro Shinozaki · Yuko Kachi · Haruo Nakamura · Haruo Nakamura
Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150–499 mg/dL) Michael S. Kelly · Craig J. Beavers · John D. Bucheit · Evan M. Sisson · Dave L. Dixon · Dave L. Dixon
Relationship between simple markers of insulin resistance and coronary artery calcification Gerald M. Reaven · Joshua W. Knowles · David Leonard · Carolyn E. Barlow · Benjamin L. Willis · William L. Haskell · David J. Maron · David J. Maron
A case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease Mathilde Di Filippo · B. Vokaer · Nabil G. Seidah · Nabil G. Seidah
Acute hyperlipidemic pancreatitis accompanied by chylous ascites with normal amylase and lipase in pregnancy Li Yang · Zhiguo Zhao · Kaiming Zhou · Yuling Zhang · Yuling Zhang
The association between six genetic variants and blood lipid levels in pregnant Chinese Han women Min Nie · Ying Wang · Wei Li · Fan Ping · Juntao Liu · Xueyan Wu · Jiangfeng Mao · Xi Wang · Liangkun Ma · Liangkun Ma
Association of serum lipid levels over time with survival in incident peritoneal dialysis patients Cheol Ho Park · Ea Wha Kang · Jung Tak Park · Seung Hyeok Han · Tae Hyun Yoo · Shin-Wook Kang · Tae Ik Chang · Tae Ik Chang
GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia Xuchen Hu · Geesje M. Dallinga-Thie · G. Kees Hovingh · Sandy Y. Chang · Norma P. Sandoval · Tiffany Ly P. Dang · Isamu Fukamachi · Kazuya Miyashita · Katsuyuki Nakajima · Masami Murakami · Loren G. Fong · Stephen G. Young · Anne P. Beigneux · Anne P. Beigneux
Treatment of Severe Hypertriglyceridemia (500 to >/= 2000 mg/dL) in 636 Patients Michael Jarman · Matan Rothschild · Kevin Lee · Ilana Schlam · Chris Mahida · Frini Makadia · Alexander Milgrom · Sarah Min · Ali Huda · Naila Goldenburg · Ping Wang · Charles J. Glueck · Charles J. Glueck
Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method Seamus P. Whelton · Seamus P. Whelton · Jeffrey W. Meeusen · Leslie J. Donato · Allan S. Jaffe · Amy K. Saenger · Lori J. Sokoll · Roger S. Blumenthal · Steven R. Jones · Seth S. Martin · Seth S. Martin · Seth S. Martin
The Majority of Outpatients With Severe Hypercholesterolemia at an Academic Tertiary Centre Have Not Been Screened for FH Ezim Ajufo · Masako Ueda · Erik Hossain · Tracey Sikora · Scott M. Damrauer · Emil M. deGoma · Kristen Dilzell · Marina Cuchel · Daniel J. Rader · Daniel J. Rader
Extended-Use, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor (PCSK9i) Data in Patients With Diabetes Mellitus: A Pharmacist-Led Initiative Joseph Bizier · Matthew Stryker · Michael P. Kane · Michael P. Kane
Differences in Cholesterol Efflux Capacity Mediated by the ABCA1, ABCG1 and SR-B1 Pathways in Patients With Acute Coronary Syndrome and Stable Coronar Xing Wu · Chongren Tang · Xue-Qiao Zhao · Moni B. Neradilek · Daniel Isquith · Mia Chen · Yang Xu · Hongwei Li · Jay W. Heinecke · Jay W. Heinecke
Retrospective Review of the Effect of Alirocumab on Apheresis Anne C. Goldberg · Michael Wooten · Richard L. Dunbar · Linda C. Hemphill · Stephan P. Babirak · Gerald Wilson · Patrick M. Moriarty · Patrick M. Moriarty
Elevated Liver Function Tests not from a Statin – A Case History of Garcina Cambogia Associated with Hepato-toxicity James Trippi · James Trippi
Progressive Reduction in LDL Levels Improves Endothelial Cell Nitric Oxide Release and Lowers Oxidative Stress in a Non-Linear Manner Richard Preston Mason · Samuel C.R. Sherratt · Hazem Dawoud · Robert F. Jacob · Tadeusz Malinski · Tadeusz Malinski
Development of Small Molecule Screening Assay for Modulation of Lipoprotein Lipase activity Using Hepatocyte Secretome Sahana Venkatesh · Prabodh Sadana · Li Lin · Li Lin
Efficacy of Alirocumab Treatment on Lipoproteins At Week 12: Pooled Analyses of 10 ODYSSEY Phase 3 Trials Eli M. Roth · Peter P. Toth · L. Veronica Lee · Jonas Mandel · Joseph Gervasio · Ulrich Laufs · Ulrich Laufs
Apolipoprotein C-III Inhibition With Volanesorsen in Patients With Hypertriglyceridemia (COMPASS): A Randomized, Double-Blind, Placebo-Controlled Trial Ioanna Gouni-Berthold · Veronica J. Alexander · Andres Digenio · Robert Dufour · Elisabeth Steinhagen-Thiessen · Steve Martin · Patrick M. Moriarty · Steve Hughes · Joseph L. Witztum · Daniel Gaudet · Eric Stroes · Eric Stroes
Lipidomic and Proteomic Predictors of Drastic Reductions of HDL in the ACCORD Lipid Trial Maryam Khavandi · Stephen Holleran · Sekhar Ramakrishnan · Amy Lovato · Henry N. Ginsberg · Henry N. Ginsberg
Salty Hypergeusia Following Lipid Ageusia Mina Alsayyab · Alan Hirsch · Alan Hirsch
Real World Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Treating Patients with Atherosclerotic Cardiovascular Disease Eddison Ramsaran · Peggy Preusse · Devi Sundaresan · Stefan DiMario · David J. Harrison · Jeetvan Patel · Jeffrey Yu · Gary Schneider · Gary Schneider
Not Just Pruritic Papules: A Potential Role of AMPK in Hypertriglyceridemia Rachna Kataria · Laia Jimena Vazquez Guillamet · Kaltrina Sedaliu · Deqiong Ma · Allen Bale · Sachin Majumdar · Sachin Majumdar
Statin Utilization Patterns Following An Acute Coronary Syndrome (ACS) Event Susan Boklage · Elisabetta Malangone-Monaco · Lorena Lopez-Gonzalez · Yao Ding · Joseph Elassal · Joseph Elassal
Predicting Cardiovascular Events in Familial Hypercholesterolemia: Validation of the Montreal-FH-SCORE Alexis Baass · Martine Paquette · Diane Brisson · Robert Dufour · Daniel Gaudet · Daniel Gaudet
Identification of Cerebrotendinous Xanthomatosis in a Child Presenting With Bilateral Cataracts P. Barton Duell · Allison R. Loh · Jill Rose · Krystal Jeffries · Andrea E. DeBarber · Andrea E. DeBarber
Association of Elevated Triglycerides and Atherogenic Lipoproteins with Incident Cardiovascular Diseases: Insights from Genetic Data in the Atherosclerosis Risk in Communities Study Anum Saeed · Elena Feofanova · Bing Yu · Salim S. Virani · Vijay Nambi · Josef Coresh · Cameron Guild · Wensheng Sun · Eric Boerwinkle · Christie M. Ballantyne · Ron C. Hoogeveen · Ron C. Hoogeveen
Overcoming Prior Authorization Barriers to PCSK9 Inhibitors with the use of Genetics Caroline Graham · Caroline Graham
Conditions Associated With a History of Extremely Low HDL-C in a US Community Health System Lars W. Andersen · Heidi Testa · Rolf Andersen · Rolf Andersen
Comparison of Two Quantitative Approaches to Diagnose Fredrickson-Levy-Lees Dyslipidemias Vasanth Sathiyakumar · Allan D. Sniderman · Steven P. Jones · Asieh Golozar · Seth S. Martin · Seth S. Martin
Subsequent Major Adverse Cardiac Events in Patients With Clinical Atherosclerotic Cardiovascular Disease and Prior Statin Use Brian Boatman · Stefan DiMario · Tanya Burton · Jerald Seare · Jeetvan Patel · David J. Harrison · David J. Harrison
Durability of Alirocumab Effect: Data From an Open-Label Extension to the ODYSSEY Program for Patients With Heterozygous Familial Hypercholesterolemia Michel Farnier · G. Kees Hovingh · Gisle Langslet · Robert Dufour · Marie T. Baccara-Dinet · Chantal Din-Bell · Garen Manvelian · John R. Guyton · John R. Guyton
Sebelipase Alfa Improves Lipid Atherogenic Biomarkers in Children and Adults With Lysosomal Acid Lipase Deficiency Don P. Wilson · Sachin Marulkar · Mark Friedman · Eric Bruckert · Eric Bruckert
Novel APOB missense variants, A224T and V925L, in a black South African woman with marked hypocholesterolemia Sharon A. Miller · Amanda J. Hooper · Amanda J. Hooper · George A. Mantiri · A. David Marais · Donald M. Tanyanyiwa · C. James McKnight · John R. Burnett · John R. Burnett · John R. Burnett
Calculated adiposity and lipid indices in healthy Arab children as influenced by vitamin D status Nasser M. Al-Daghri · Shaun Sabico · Yousef Al-Saleh · Yousef Al-Saleh · Omar S. Al-Attas · Abdullah M. Alnaami · Marwan M. AlRehaili · Mohammed M. Al-Harbi · Hanan Alfawaz · George P. Chrousos · George P. Chrousos · Majed S. Alokail · Majed S. Alokail
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial Patrick M. Moriarty · Klaus G. Parhofer · Stephan P. Babirak · Emil M. deGoma · P. Barton Duell · Bernd Hohenstein · Wolfgang Ramlow · Vinaya Simha · Elisabeth Steinhagen-Thiessen · Paul D. Thompson · Anja Vogt · Berndt von Stritzky · Yunling Du · Garen Manvelian · Garen Manvelian
Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study Byung Jin Kim · Eun Sun Cheong · Jung Gyu Kang · Bum Soo Kim · Jin Ho Kang · Jin Ho Kang
Epicardial adipose tissue-Truly at the heart of the coronaries? Binh An P. Phan · Samira Bahrainy · Edward A. Gill · Edward A. Gill
Genetic diagnosis of familial hypercholesterolemia in Han Chinese Kuan-Rau Chiou · Min-Ji Charng · Min-Ji Charng · Min-Ji Charng
Rare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemia Isabel De Castro-Orós · Fernando Civeira · María Jesús Pueyo · Rocío Mateo-Gallego · Alfonso Bolado-Carrancio · Itziar Lamiquiz-Moneo · Luis Álvarez-Sala · Fernando Fabiani · Montserrat Cofán · Ana Cenarro · José Carlos Rodríguez-Rey · Emilio Ros · Miguel Pocovi · Miguel Pocovi
Changes in carotid plaque tissue composition in subjects who continued and discontinued statin therapy Ruixue Du · Xue Qiao Zhao · Jianming Cai · Bao Cui · Hong Mei Wu · Ping Ye · Ping Ye
Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients Omid Toupchian · Gity Sotoudeh · Anahita Mansoori · Anahita Mansoori · Ensieh Nasli-Esfahani · Mahmoud Djalali · Seyyed Ali Keshavarz · Fariba Koohdani · Fariba Koohdani
Placental DHA and mRNA levels of PPARγ and LXRα and their relationship to birth weight Akshaya Meher · Nisha Wadhwani · Karuna Randhir · Savita Mehendale · Girija Wagh · Sadhana Joshi · Sadhana Joshi
JCL Roundtable: Should we treat elevations in Lp(a)? W. Virgil Brown · Patrick M. Moriarty · Alan T. Remaley · Sotirios Tsimikas · Sotirios Tsimikas
Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 years Nina R. Joyce · Nina R. Joyce · Gregory A. Wellenius · Charles B. Eaton · Amal N. Trivedi · Justin P. Zachariah · Justin P. Zachariah · Justin P. Zachariah · Justin P. Zachariah
Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis Claudia Stefanutti · Claudia Morozzi · Serafina Di Giacomo · Barbara Sovrano · Dario Mesce · Alberto Grossi · Alberto Grossi
The very high residual degree of death and disease from atherosclerosis needs new approaches Michael E. Makover · Michael Schloss · Michael Schloss
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations Claudio Rabacchi · Federico Bigazzi · M. Puntoni · Francesco Sbrana · T. Sampietro · Patrizia Tarugi · Stefano Bertolini · Sebastiano Calandra · Sebastiano Calandra
Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes Amy S. Shah · W. Sean Davidson · Zhiqian Gao · Lawrence M. Dolan · Thomas R. Kimball · Elaine M. Urbina · Elaine M. Urbina
Characterization of the unique Chinese W483X mutation in the low-density lipoprotein–receptor gene in young patients with homozygous familial hypercholesterolemia Long Jiang · Li-Yuan Sun · Xiao-Dong Pan · Pan-Pan Chen · Pan-Pan Chen · Ling Tang · Ling Tang · Wei Wang · Wei Wang · Li-Min Zhao · Shi-Wei Yang · Lu-Ya Wang · Lu-Ya Wang
Comment on the article by Moriarty et al Connie B. Newman · Jonathan A. Tobert · Jonathan A. Tobert
Comparison of different statin therapy to change low-density lipoprotein cholesterol and high-density lipoprotein cholesterol level in Korean patients with and without diabetes Ah Reum Khang · Young Shin Song · Kyoung Min Kim · Jae Hoon Moon · Soo Lim · Soo Lim · Kyong Soo Park · Hak Chul Jang · Hak Chul Jang · Sung Hee Choi · Sung Hee Choi · Sung Hee Choi
Impact of epidermal fatty acid binding protein on 2D-NMR–assessed atherogenic dyslipidemia and related disorders Daiana Ibarretxe · Josefa Girona · Núria Amigó · Núria Plana · Raimon Ferré · Sandra Guaita · Roger Mallol · Mercedes Heras · Luis Masana · Luis Masana
Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes Jennifer L. Jarvie · Hong Wang · Gregory L. Kinney · Janet K. Snell-Bergeon · John E. Hokanson · Robert H. Eckel · Robert H. Eckel
Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis Hala Hussein · Hala Hussein · Samir Saheb · Martine Couturier · Marielle Atassi · Alexina Orsoni · Alexina Orsoni · Alain Carrié · Alain Carrié · Patrice Therond · Paul Robillard · Paul Robillard · Eric Bruckert · M. John Chapman · M. John Chapman · Anatol Kontush · Anatol Kontush · Anatol Kontush
A tale of 2 cousins: An atypical and a typical case of abetalipoproteinemia Martine Paquette · Robert Dufour · Robert A. Hegele · Alexis Baass · Alexis Baass
Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies Thomas Knickelbine · Matthew Lui · Ross Garberich · Michael D. Miedema · Craig Strauss · Jeffrey J. VanWormer · Jeffrey J. VanWormer
Tendon xanthomas: Not always familial hypercholesterolemia Charlotte Koopal · Frank L.J. Visseren · A. David Marais · Jan Westerink · Wilko Spiering · Wilko Spiering
Examining barriers to cascade screening for familial hypercholesterolemia in the United States Rolf Andersen · Lars W. Andersen · Lars W. Andersen
An unusual cause of Achilles tendon xanthoma Fabienne Parente · Matthew Vesnaver · Rami Massie · Alexis Baass · Alexis Baass

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: a case report and literature review
Journal of Clinical Lipidology | 2018
Ryoichi Ishibashi · Minoru Takemoto · Minoru Takemoto · Yuya Tsurutani · Masayuki Kuroda · Makoto Ogawa · Hanae Wakabayashi · Noriko Uesugi · Michio Nagata · Naofumi Imai · Akiko Hattori · Kenichi Sakamoto · Takumi Kitamoto · Yoshiro Maezawa · Ichiei Narita · Sadayuki Hiroi · Ayaka Furuta · Takashi Miida · Koutaro Yokote · Koutaro Yokote
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span
Journal of Clinical Lipidology | 2018
Lauren Williams · Katherine S. Rhodes · Wahida Karmally · Lori A. Welstead · Lori Alexander · Lindsey Sutton · Lindsey Sutton